Omnicomm Systems (OMCM) 10-K 28 Mar 17 2016 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2016	Mar. 27, 2017	Jun. 30, 2016
Document Information [Line Items]
Entity Registrant Name	OMNICOMM SYSTEMS INC
Entity Central Index Key	1,034,592
Trading Symbol	omcm
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		147,770,249
Entity Public Float			$ 19,500,958
Document Type	10-K
Document Period End Date	Dec. 31, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	FY
Amendment Flag	false

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2016	Dec. 31, 2015
CURRENT ASSETS
Cash	$ 1,439,332	$ 835,219
Accounts receivable, net of allowance for doubtful accounts of $179,813 and $116,834, respectively	5,455,210	4,092,472
Prepaid expenses	195,915	170,173
Prepaid stock compensation, current portion	148,422	175,858
Other current assets	35,055	14,351
Total current assets	7,273,934	5,288,073
Property and equipment, net	637,552	683,712
Intangible assets, net	108,880	148,877
Prepaid stock compensation	58,663	150,085
Other assets	51,321	46,565
TOTAL ASSETS	8,130,350	6,317,312
CURRENT LIABILITIES
Accounts payable and accrued expenses	2,123,073	1,957,270
Deferred revenue, current portion	7,250,061	7,054,614
Convertible notes payable, current portion	50,000	75,000
Conversion feature liability, related parties	1,479,748	561,137
Total current liabilities	16,610,726	12,865,550
LONG TERM LIABILITIES
Line of credit, long term	2,700,000	4,200,000
Notes payable, related parties, long term, net of current portion, net of discount of $237,664 and $-0-, respectively	212,336	20,000
Notes payable, long term, net of current portion, net of discount of $455,285 and $-0-, respectively	337,215	792,500
Deferred revenue, long term, net of current portion	2,289,169	2,193,163
Convertible notes payable, related parties, long term, net of current portion	5,825,000	5,850,000
Convertible notes payable, long term, net of current portion	1,175,000	1,350,000
Patent settlement liability, long term, net of current portion	108,702	464,573
TOTAL LIABILITIES	29,258,148	27,735,786
COMMITMENTS AND CONTINGENCIES (See Note 10)
SHAREHOLDERS' (DEFICIT)
Preferred stock	0	0
Common stock, 500,000,000 shares authorized, 147,786,917 and 131,703,577 issued and outstanding, respectively, at $0.001 par value	147,788	131,704
Additional paid in capital - preferred	999,750	4,230,792
Additional paid in capital - common	53,425,956	49,974,415
Accumulated other comprehensive (loss)	(410,505)	(366,355)
Accumulated (deficit)	(75,291,037)	(75,392,917)
TOTAL SHAREHOLDERS' (DEFICIT)	(21,127,798)	(21,418,474)
TOTAL LIABILITIES AND SHAREHOLDERS' (DEFICIT)	8,130,350	6,317,312
Series B Preferred Stock [Member]
SHAREHOLDERS' (DEFICIT)
Preferred stock	0	0
Series C Preferred Stock [Member]
SHAREHOLDERS' (DEFICIT)
Preferred stock	0	0
Series A Preferred Stock [Member]
SHAREHOLDERS' (DEFICIT)
Preferred stock	0	3,637
TOTAL SHAREHOLDERS' (DEFICIT)	0	3,637
Series D Preferred Stock [Member]
SHAREHOLDERS' (DEFICIT)
Preferred stock	250	250
TOTAL SHAREHOLDERS' (DEFICIT)	250	250
Conversion Feature Liability Related Parties [Member]
CURRENT LIABILITIES
Patent settlement liability, current portion	862,500	962,500
Conversion Feature Liability [Member]
CURRENT LIABILITIES
Conversion feature liability, related parties	1,740,278	535,835
Warrant Liability Related Parties [Member]
CURRENT LIABILITIES
Conversion feature liability, related parties	585,452	365,408
Warrant Liability [Member]
CURRENT LIABILITIES
Conversion feature liability, related parties	$ 2,519,614	$ 1,353,786

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Allowance for doubtful accounts	$ 179,813	$ 116,834
Notes payable discount
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares undesignated	$ 3,772,500	$ 3,772,500
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	147,786,917	131,703,577
Common stock, shares outstanding (in shares)	147,786,917	131,703,577
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Series B Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	230,000	230,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Preferred stock, liquidation preference	$ 0	$ 0
Series C Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	747,500	747,500
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Preferred stock, liquidation preference	$ 0	$ 0
Series A Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Preferred stock, shares issued (in shares)	0	3,637,724
Preferred stock, shares outstanding (in shares)	0	3,637,724
Preferred stock, liquidation preference	$ 0	$ 3,637,724
Series D Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	250,000	250,000
Preferred stock, shares issued (in shares)	250,000	250,000
Preferred stock, shares outstanding (in shares)	250,000	250,000
Related Party Long Term [Member]
Notes payable discount	$ 237,664	$ 0
Notes Payable, Other Payables [Member]
Notes payable discount	$ 455,285	$ 0

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Revenues	$ 24,394,010	$ 20,023,733
Reimbursable revenues	1,025,500	687,104
Total revenues	25,419,510	20,710,837
Cost of goods sold	3,913,407	3,770,013
Reimbursable expenses-cost of goods sold	1,461,425	677,568
Total cost of goods sold	5,374,832	4,447,581
Gross margin	20,044,678	16,263,256
Operating expenses
Salaries, benefits and related taxes	11,383,727	10,602,686
Rent and occupancy expenses	1,071,363	972,862
Consulting services	185,340	253,626
Legal and professional fees	364,859	415,834
Travel	774,379	779,817
Telephone and internet	164,014	166,361
Selling, general and administrative	1,462,774	1,530,765
Bad debt expense	132,767	14,939
Depreciation expense	302,893	233,798
Amortization expense	37,331	40,338
Total operating expenses	15,879,447	15,011,026
Operating income/(loss)	4,165,231	1,252,230
Other income/(expense)
Interest expense, related parties	(918,189)	(2,434,101)
Interest expense	(421,713)	(299,668)
Interest income	2	4
Change in derivative liabilities	(2,657,910)	4,525,798
Impairment of goodwill	0	(536,285)
Other income	0	124,373
Transaction gain/(loss)	(64,472)	(70,706)
Income/(loss) before income taxes	102,949	2,561,645
Income tax (expense)	(1,069)	24,739
Net income/(loss)	101,880	2,586,384
Preferred stock dividends
Series A preferred	0	(181,886)
Net income/(loss) attributable to common stockholders	$ 101,880	$ 2,404,498
Net income/(loss) per share
Basic (in dollars per share)	$ 0	$ 0.02
Diluted (in dollars per share)	$ 0	$ 0.02
Weighted average number of shares outstanding
Basic (in shares)	145,868,227	96,645,482
Diluted (in shares)	146,162,427	113,545,741

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income/(Loss) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Net income/(loss) attributable to common stockholders	$ 101,880	$ 2,404,498
Other comprehensive income/(loss)
Change in foreign currency translation adjustment	(44,150)	(122,528)
Other comprehensive income/(loss)	(44,150)	(122,528)
Comprehensive income/(loss)	$ 57,730	$ 2,281,970

Consolidated Statement of Share

Consolidated Statement of Shareholders' (Deficit) - USD ($)	Series A Preferred Stock [Member]	Series D Preferred Stock [Member]	Additional Paid In Capital Preferred [Member]	Common Stock [Member]	Additional Paid In Capital Common [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Balance (in shares) at Dec. 31, 2014	4,125,224	250,000		91,561,802
Balance at Dec. 31, 2014	$ 4,125	$ 250	$ 4,717,804	$ 91,562	$ 37,634,555	$ (77,979,301)	$ (243,827)	$ (35,774,832)
Employee stock option expense					43,090			43,090
Change in foreign currency translation adjustment							(122,528)	(122,528)
Restricted stock issuance/(forfeiture) (in shares)				908,330
Restricted stock issuance/(forfeiture)				$ 908	226,875			$ 227,783
Issuance of common stock, stock option exercise (in shares)				252,500				292,500
Issuance of common stock, stock option exercise				$ 253	26,997			$ 27,250
Cashless issuance of common stock, stock option exercise (in shares)				7,428
Cashless issuance of common stock, stock option exercise				$ 7	(7)			0
Issuance of common stock, in exchange for Series A Preferred Stock (in shares)	(487,500)			1,950,000
Issuance of common stock, in exchange for Series A Preferred Stock	$ (488)		(487,012)	$ 1,950	485,550			0
Issuance of common stock in exchange for converted and cancelled debt and cancelled warrants (in shares)				37,023,517
Issuance of common stock in exchange for converted and cancelled debt and cancelled warrants				$ 37,024	11,557,355			11,594,379
Net income/(loss)	$ 0	$ 0	0	$ 0	0	2,586,384	0	2,586,384
Balance (in shares) at Dec. 31, 2015	3,637,724	250,000		131,703,577
Balance at Dec. 31, 2015	$ 3,637	$ 250	4,230,792	$ 131,704	49,974,415	(75,392,917)	(366,355)	(21,418,474)
Employee stock option expense					35,046			35,046
Change in foreign currency translation adjustment							(44,150)	(44,150)
Restricted stock issuance/(forfeiture) (in shares)				360,000
Restricted stock issuance/(forfeiture)				$ 360	68,040			$ 68,400
Issuance of common stock, stock option exercise (in shares)				1,100,000				1,120,000
Issuance of common stock, stock option exercise				$ 1,100	128,400			$ 129,500
Cashless issuance of common stock, stock option exercise (in shares)				7,644
Cashless issuance of common stock, stock option exercise				$ 8	(8)			0
Issuance of common stock, in exchange for Series A Preferred Stock (in shares)	(3,637,724)			14,615,696
Issuance of common stock, in exchange for Series A Preferred Stock	$ (3,637)		(3,231,042)	$ 14,616	3,220,063			0
Net income/(loss)	$ 0	$ 0	0	$ 0	0	101,880	0	101,880
Balance (in shares) at Dec. 31, 2016	0	250,000		147,786,917
Balance at Dec. 31, 2016	$ 0	$ 250	$ 999,750	$ 147,788	$ 53,425,956	$ (75,291,037)	$ (410,505)	$ (21,127,798)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net income/(loss)	$ 101,880	$ 2,586,384
Adjustment to reconcile net income/(loss) to net cash provided by/(used in) operating activities
Change in derivative liabilities	2,657,910	(4,525,798)
Impairment of goodwill	0	536,285
Interest expense from derivative instruments	158,068	611,089
Employee stock compensation	222,304	245,083
Provision for doubtful accounts	132,767	14,939
Depreciation and amortization	340,224	274,136
Changes in operating assets and liabilities
Accounts receivable	(1,495,505)	(691,260)
Prepaid expenses	(25,742)	57,909
Other current assets	(20,704)	3,954
Other assets	(4,756)	2,527
Accounts payable and accrued expenses	615,803	733,085
Patent settlement liability	(455,871)	(205,252)
Deferred revenue	291,453	1,013,834
Net cash provided by/(used in) operating activities	2,517,831	656,915
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment	(260,378)	(450,707)
Net cash (used in) investing activities	(260,378)	(450,707)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayments of notes payable	(245,000)	(75,000)
Proceeds/(repayments) from revolving line of credit	(1,500,000)	200,000
Proceeds from Stock Options Exercised	129,500	27,250
Net cash provided by/(used in) financing activities	(1,615,500)	152,250
Effect of exchange rate changes on fixed and intangible assets	6,310	76,375
Effect of exchange rate changes on cash and cash equivalents	(44,150)	(122,528)
Net increase/(decrease) in cash and cash equivalents	604,113	312,305
Cash and cash equivalents at beginning of period	835,219	522,914
Cash and cash equivalents at end of period	1,439,332	835,219
Supplemental disclosures of cash flow information:
Income taxes	1,069	(24,739)
Interest	1,445,684	1,457,028
Non-cash transactions:
Restricted stock issuance/(forfeiture)	68,400	227,783
Common stock issued in exchange for 5% Series A Preferred Stock	3,637,724	487,500
Notes payable and warrants cancelled in exchange for common stock	0	7,339,000
Notes payable converted into common stock	0	1,915,000
Promasys B.V. [Member]
Non-cash transactions:
Promissory notes issued for accrued interest	450,000	670,000
Notes Payable Issued For Existing Notes Payable [Member]
Non-cash transactions:
Debt Conversion, Original Debt, Amount	$ 7,652,500	$ 20,193,000

Note 1 - Organization and Natur

Note 1 - Organization and Nature of Operations	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Nature of Operations [Text Block]	NOTE 1: ORGANIZATION AND NATURE OF OPERATIONS OmniComm Systems, Inc. (“OmniComm” or the “Company”) is a healthcare te chnology company that provides web-based electronic data capture (“EDC”) solutions and related value-added services to pharmaceutical and biotechnology companies, clinical research organizations(“CROs”), and other clinical trial sponsors principally located in the United States, Europe and East Asia. Our proprietary EDC software applications; TrialMaster ® ; TrialOne ® ; Promasys ® ; and eClinical Suite, allow clinical trial sponsors and investigative sites to securely collect, validate, transmit, and analyze clinical trial data. Our ability to compete within the EDC industry is predicated on our ability to continue enhancing and broadening the scope of solutions offered through our EDC software and services. Our efforts are focused on developing new and complementary software solutions, as well as enhancing our existing software solutions, through the addition of increased functionality. During the years ended December 31, 2016 December 31, 2015 $2,598,962 $2,639,577, activities, which is primarily comprised of salaries to our developers and other personnel and related costs associated with the development of our software products

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Significant Accounting Policies [Text Block]	NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION The Company ’s accounts include those of all its wholly-owned subsidiaries and have been prepared in conformity with (i) accounting principles generally accepted in the United States of America; and (ii) the rules and regulations of the United States Securities and Exchange Commission. All significant intercompany accounts and transactions between the Company and its subsidiaries have been eliminated in consolidation. ESTIMATES IN FINANCIAL STATEMENTS The preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Significant estimates incorporated in our financial statements include the recorded allowance for doubtful accounts, the estimate of the appropriate amortization period of our intangible assets, the evaluation of whether our intangible assets have suffered any impairment, the allocation of revenues under multiple-element customer contracts, royalty-based patent liabilities, the value of derivatives associated with debt issued by the Company and the valuation of any corresponding discount to the issuance of our debt. Actual results may RECLASSIFICATIONS Certain reclassifications have been made in the 2015 2016 FOREIGN CURRENCY TRANSLATION The financial statements of the Company ’s foreign subsidiaries are translated in accordance with ASC 830 30, Foreign Currency Matters—Translation of Financial Statements $44,150 December 31, 2016 $122,528 December 31, 2015. REVENUE RECOGNITION POLICY The Company derives revenues from software licenses and services of its EDC products and services which can be purchased on a stand-alone basis. License revenues are derived principally from the sale of term licenses for the following software products offered by the Company: TrialMaster, TrialOne , Promasys eClinical Suite ( “EDC Software”). TrialMaster eClinical Suite The Company recognizes revenues when all of the following conditions are satisfied: (1) there is persuasive evidence of an arrangement; (2) (3) (4) The Company operates in one The Company segregates its revenues based on the activity cycle used to generate its revenues. Accordingly, revenues are currently generated through four Hosted Application Revenues The Company offers its TrialMaster eClinical Suite Revenues resulting from TrialMaster eClinical Suite three first second third Fees charged and costs incurred for the trial system design, set up and implementation are amortized and recognized ratably over the estimated hosting period. Work performed outside the original scope of work is contracted for separately as an additional fee and is generally recognized ratably over the remaining term of the hosting period. Fees for the first third second eClinical Suite Licensing Revenues The Company's software license revenues are earned from the sale of off-the-shelf software. From time-to-time a client might require significant modification or customization subsequent to delivery to the customer. The Company generally enters into software term licenses for its EDC Software products with its customers for 3 5 30 45 In the past the Company has sold perpetual licenses for EDC Software products in certain situations to existing customers with the option to purchase customer support, and may The Company generates customer support and maintenance revenues from its perpetual license customer base. Professional Services The Company may Subsequent additions or extensions to license terms do not generally include additional professional services. Maintenance Revenues Maintenance includes telephone-based help desk support and software maintenance. The Company generally bundles customer support with the software license for the entire term of the arrangement. As a result, the Company generally recognizes revenues for both maintenance and software licenses ratably over the term of the software license and support arrangement. The Company allocates the revenues recognized for these arrangements to the different elements based on management's estimate of the relative fair value of each element. The Company generally invoices each of the elements based on separately quoted amounts and thus has a fairly accurate estimate of the relative fair values of each of the invoiced revenue elements. The fees associated with each business activity for the years ended December 31, 2016 December 31, 2015, For the year ended Revenue activity December 31, 2016 December 31, 2015 Set-up fees $ 6,658,987 $ 6,649,762 Change orders 1,212,153 846,464 Maintenance 4,803,171 5,107,764 Software licenses 7,885,023 3,975,549 Professional services 3,843,641 3,145,883 Hosting 1,016,535 985,415 Total $ 25,419,510 $ 20,710,837 COST OF GOODS SOLD Cost of goods sold primarily consists of costs related to hosting, maintaining and supporting the Company ’s application suite and delivering professional services and support. These costs include salaries, benefits, bonuses and stock-based compensation for the Company’s professional services staff. Cost of goods sold also includes outside service provider costs . CASH AND CASH EQUIVALENTS Cash equivalents consist of highly liquid, short-term investments with maturities of 90 The carrying amount reported in the accompanying consolidated balance sheets approximates fair value. ACCOUNTS RECEIVABLE Accounts receivable are judged as to collectability by management and an allowance for bad debts is established as necessary. The allowance is based on an evaluation of the collectability of accounts receivable and prior bad debt experience. The Company had recorded an allowance for uncollectible accounts receivable of $179,813 December 31, 2016 $116,834 December 31, 2015. The following table summarizes activity in the Company's allowance for doubtful accounts for the years presented. December 31, 2016 December 31, 2015 Beginning of period $ 116,834 $ 186,085 Bad debt expense 132,767 14,939 Write-offs (69,788 ) (84,190 ) End of period $ 179,813 $ 116,834 CONCENTRATION OF CREDIT RISK Cash and cash equivalents and restricted cash are deposited with major financial institutions and, at times, such balances with any one may December 31, 2016, $1,237,118 Except as follows, the Company has no significant off balance sheet risk or credit risk concentrations. Financial instruments that subject the Company to potential credit risks are principally cash equivalents and accounts receivable. Concentrated credit risk with respect to accounts receivable is limited to creditworthy customers. The Company's customers are principally located in the United States, Europe and East Asia. The Company is directly affected by the overall financial condition of the pharmaceutical, biotechnology and medical device industries and management believes that credit risk exists and that any credit risk the Company faces has been adequately reserved for as of December 31, 2016. December 31, 2016, One customer accounted for 16% December 31, 2016 $4,167,000, 16% December 31, 2015 $3,237,000. 10% Two customers each individually accounted for approximately 11% December 31, 2016. 16% December 31, 2015. Revenues Accounts receivable For the year ended Number of customers Percentage of total revenues Number of customers Percentage of accounts receivable December 31, 2016 1 16% 2 21% December 31, 2015 1 16% 3 42% The table below provides revenues from European customers for the years ended December 31, 2016 December 31, 2015, European revenues For the year ended December 31, 2016 December 31, 2015 European revenues % of Total revenues European revenues % of Total revenues $ 2,702,660 11% $ 2,150,096 10% The Company serves all of its hosting customers from third third may PROPERTY AND EQUIPMENT Property and equipment are recorded at cost. Additions and betterments are capitalized; maintenance and repairs are expensed as incurred. Depreciation is calculated using the straight-line method over the asset’s estimated useful life, which is 5 3 ASSET IMPAIRMENT Acquisitions and Intangible Assets We account for acquisitions in accordance with ASC 805, Business Combinations 805”) 350, Intangibles- Goodwill and Other 350”). The judgments that we make in determining the estimated fair value assigned to each class of assets acquired and liabilities assumed, as well as asset lives, can materially impact net income in periods following an asset acquisition. We generally use either the income, cost or market approach to aid in our conclusions of such fair values and asset lives. The income approach presumes that the value of an asset can be estimated by the net economic benefit to be received over the life of the asset, discounted to present value. The cost approach presumes that an investor would pay no more for an asset than its replacement or reproduction cost. The market approach estimates value based on what other participants in the market have paid for reasonably similar assets. Although each valuation approach is considered in valuing the assets acquired, the approach ultimately selected is based on the characteristics of the asset and the availability of information. Long-lived Assets We review long-lived assets for impairment whenever events or changes in circumstances indicate that the related carrying amounts may ’s residual value, if any. In turn, measurement of an impairment loss requires a determination of fair value, which is based on the best information available. We use quoted market prices when available and independent appraisals and management estimates of future operating cash flows, as appropriate, to determine fair value. DEFERRED REVENUE Deferred revenue represents cash advances received in excess of revenue earned on on-going contracts. Payment terms vary with each contract but may December 31, 2016, $9,539,230 1 5 $7,250,061 twelve ADVERTISING Advertising costs are expensed as incurred. Advertising costs were $712,179 December 31, 2016 $635,267 December 31, 2015 RESEARCH AND PRODUCT DEVELOPMENT EXPENSES Software development costs are included in research and product development and are expensed as incurred. ASC 985.20, 985.20. December 31, 2016 $2,598,962 December 31, 2015 $2,639,577, activities, which include costs associated with the development of our software products and services for our client’s projects and which are primarily comprised of salaries and related expenses for our software developers and consulting fees paid to third costs are primarily included under Salaries, benefits and related taxes in our Statement of Operations. EMPLOYEE EQUITY INCENTIVE PLANS The OmniComm Systems, Inc. 2016 “2016 June 16, 2016. The 2016 10,000,000 2016 January 1st nine (9) January 1, 2017 January 1, 2025, five (5%) 2016 The predecessor plan, the OmniComm Systems, Inc. 2009 “2009 July 10, 2009 June 16, 2016 2016 The 2009 7.5 2009 Each plan is more fully described in “Note 13, ASC 718, ASC 718 ’s consolidated statements of operations. The Company currently uses the Black Scholes option pricing model to determine grant date fair value. EARNINGS/(LOSS) PER SHARE The Company accounts for Earnings/(loss) Per Share using ASC 260 – Earnings per Share. Unlike diluted earnings per share, basic earnings per share excludes any dilutive effects of options, warrants, and convertible securities. INCOME TAXES The Company accounts for income taxes in accordance with ASC 740, 740 Valuation allowances are established, when necessary, to reduce deferred tax assets to the estimated amount to be realized. Income tax expense represents the tax payable for the current period and the change during the period in the deferred tax assets and liabilities. IMPACT OF NEW ACCOUNTING STANDARDS During fiscal 2016, In February 2016, ASU”) No. 2016 02, “Leases (Topic 842)” 2016 02”). 12 December 15, 2019. In March 2016, ASU No. 2016 09, “Compensation – Stock Compensation (Topic 718)”, 2016 09”). December 15, 2016, In March 2016, April 2016, December 2016, 2016 08, Revenue from Contracts with Customers - Principal versus Agent Considerations (Reporting Revenue Gross versus Net) 2016 08”), 2016 10, Revenue from Contracts with Customers - Identifying Performance Obligations and Licensing 2016 10”), 2016 20, Technical Corrections and Improvements to Topic 606, 2016 20”) 2014 09. May 2016, 2016 12, Revenue from Contracts with Customers - Narrow Scope Improvements and Practical Expedients 2014 09, December 15, 2016, Accounting standards-setting organizations frequently issue new or revised accounting rules. We regularly review all new pronouncements to determine their impact, if any, on our financial statements.

Note 3 - Earnings (Loss) Per Sh

Note 3 - Earnings (Loss) Per Share	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Earnings Per Share [Text Block]	NOTE 3: EARNINGS/(LOSS) PER SHARE Basic income/(loss) per share was calculated using the weighted average number of shares outstanding of 145,868,227 December 31, 2016 96,645,482 December 31, 2015. Anti-dilutive shares aggregating 43,775,016 for the year ended December 31, 2016 27,356,310 December 31, 2015 December 31, 2016 December 31, 2015 December 31, 2016 December 31, 2015. Anti-dilutive security December 31, 2016 December 31, 2015 Preferred stock -0- 3,277,229 Employee stock options 275,000 125,000 Warrants 27,860,000 22,900,000 Convertible notes 15,490,000 -0- Shares issuable for accrued interest 150,016 1,054,081 Total 43,775,016 27,356,310 The employee stock options are exercisable at prices ranging from $0.045 $0.24 per share. The exercise price on the stock warrants range from $0.25 $0.60 $0.25 $0.50 The Company ’s convertible debt and convertible preferred stock have an anti-dilutive effect on net income/(loss) per share and were not included in the computation of diluted income/(loss) per share. For the year ended December 31, 2016 December 31, 2015 Income/(loss) Shares Per-share Income/(loss) Shares Per-share numerator denominator amount numerator denominator amount Basic EPS $ 101,880 145,868,227 $ 0.00 $ 2,404,498 96,645,482 $ 0.02 Effect of dilutive securities -0- 294,200 0.00 43,316 16,900,259 0.00 Diluted EPS $ 101,880 146,162,427 $ 0.00 $ 2,447,814 113,545,741 $ 0.02

Note 4 - Property and Equipment

Note 4 - Property and Equipment, Net	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	NOTE 4 : PROPERTY AND EQUIPMENT, NET Property and equipment consists of the following: December 31, 2016 December 31, 2015 Cost Accumulated depreciation Net book value Cost Accumulated depreciation Net book value Estimated useful life (years) Computer & office equipment $ 2,125,067 $ 1,761,879 $ 363,188 $ 2,055,956 $ 1,605,473 $ 450,483 5 Leasehold improvements 114,719 89,789 24,930 91,452 85,895 5,557 5 Computer software 1,925,462 1,720,399 205,063 1,843,483 1,621,492 221,991 3 Office furniture 158,436 114,065 44,371 111,660 105,979 5,681 5 Total $ 4,323,684 $ 3,686,132 $ 637,552 $ 4,102,551 $ 3,418,839 $ 683,712 Depreciation expense was $302,893 December 31, 2016 $233,798 December 31, 2015.

Note 5 - Intangible Assets, Net

Note 5 - Intangible Assets, Net	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Intangible Assets Disclosure [Text Block]	NOTE 5 : INTANGIBLE ASSETS, NET Intangible assets consist of the following: December 31, 2016 December 31, 2015 Cost Accumulated amortization Net book value Cost Accumulated amortization Net book value Estimated useful life (years) eClinical Suite customer list $ 1,392,701 $ 1,392,701 $ -0- $ 1,392,701 $ 1,392,701 $ -0- 3 Promasys B.V. customer list 104,163 21,990 82,173 108,051 15,607 92,444 15 Promasys B.V. software code 72,837 46,130 26,707 72,837 31,563 41,274 5 Promasys B.V. URLs/website 52,608 52,608 -0- 54,572 39,413 15,159 3 Total $ 1,622,309 $ 1,513,429 $ 108,880 $ 1,628,161 $ 1,479,284 $ 148,877 Amortization expense was $ 37,331 December 31, 2016 $40,338 December 31, 2015. Annual amortization expense for the Company ’s intangible assets is as follows: 2017 $ 21,512 2018 19,084 2019 6,944 2020 6,944 2021 6,944 Thereafter 47,452 Total $ 108,880

Note 6 - Accounts Payable and A

Note 6 - Accounts Payable and Accrued Expenses	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	NOTE 6 : ACCOUNTS PAYABLE AND ACCRUED EXPENSES Accounts payable and accrued expenses consist of the following: Account​ December 31, 2016 December 31, 2015 Accounts payable $ 697,060 $ 515,764 Accrued payroll and related costs 886,334 473,108 Other accrued expenses 431,961 105,562 Accrued interest 107,718 862,836 Total accounts payable and accrued expenses $ 2,123,073 $ 1,957,270

Note 7 - Line of Credit, Notes

Note 7 - Line of Credit, Notes Payable and Liquidity	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Debt Disclosure [Text Block]	NOTE 7: LINE OF CREDIT, NOTES PAYABLE AND LIQUIDITY On March 18, 2013, $2,000,000 2.0% $9,500 December 18, 2013 $4,000,000. February 3, 2015 $5,000,000. February 2, 2018 December 31, 2016, $2,700,000 2.75%. Our primary sources of working capital are funds from operations and borrowings under our revolving Line of Credit. In the event that the line of credit is called for any reason, Mr. Wit has pledged to replace the borrowing capacity under the Line of Credit with a promissory note that utilizes the same maturity date and interest rate as the Line of Credit. To satisfy our capital requirements, we may may may At December 31, 2016, $1,242,500 Ending principal Non related party Related party Origination Maturity Interest December 31, Long Long date date rate 2016 Current term Current term 2/29/2016 4/1/2019 12% $ 450,000 $ -0- $ -0- $ -0- $ 450,000 6/30/2016 4/1/2020 10% 420,000 -0- 420,000 -0- -0- 6/30/2016 4/1/2020 12% 372,500 -0- 372,500 -0- -0- Discount on notes payable -0- (455,285 ) -0- (237,664 ) Total $ 1,242,500 $ -0- $ 337,215 $ -0- $ 212,336 At December 31, 2015, $812,500 Ending principal Non related party Related party Origination Maturity Interest December 31, Long Long date date rate 2015 Current term Current term 4/4/2014 4/1/2017 12% $ 45,000 $ -0- $ 45,000 $ -0- $ -0- 4/4/2014 4/1/2017 12% 137,500 -0- 137,500 -0- -0- 4/4/2014 4/1/2017 10% 120,000 -0- 120,000 -0- -0- 12/1/2014 4/1/2017 10% 300,000 -0- 300,000 -0- -0- 12/1/2014 4/1/2017 12% 90,000 -0- 90,000 -0- -0- 12/1/2014 4/1/2017 12% 100,000 -0- 100,000 -0- -0- 4/1/2015 4/1/2018 12% 20,000 -0- -0- -0- 20,000 Discount on notes payable -0- -0- -0- -0- Total $ 812,500 $ -0- $ 792,500 $ -0- $ 20,000 On February 29, 2016, $450,000 1,800,000 $0.25 April 1, 2019 $450,000. 12% April 1, 2019. On December 5, 2016 1,000,000 This issuance caused us to calculate and record a derivative liability for the warrant liability. The warrants were valued using the Black Scholes option pricing model. A value of $325,689 $124,311. 37 On June 30, 2016, $372,500 1,490,000 $0.25 April 1, 2020 two 12% April 1, 2020. On December 14, 2016 $90,000 This issuance caused us to calculate and record a derivative liability for the warrant liability. The warrants were valued using the Black Scholes option pricing model. A value of $246,921 $125,579. 45 On June 30, 2016, $420,000 1,680,000 $0.25 April 1, 2020 two 10% April 1, 2020. This issuance caused us to calculate and record a derivative liability for the warrant liability. The warrants were valued using the Black Scholes option pricing model. A value of $278,408 $141,592. 45 On January 31, 2015 $529,000 Mr. Wit in exchange for an existing promissory note in the same amount. The promissory note carries an interest rate of 12% April 1, 2017. April 1, 2017. October 15, 2015 $529,000 12% January 1, 2019. January 1, 2019. November 19, 2015 2,116,000 On January 31, 2015 $2,860,000 $6,879 12% April 1, 2017. April 1, 2017. October 15, 2015 $2,860,000 12% January 1, 2019. January 1, 2019. November 19, 2015 11,440,000 11,440,000 On January 31, 2015, $950,000 3,800,000 Company at an exercise price of $0.25 April 1, 2017 $280,000 $670,000. 12% April 1, 2017. October 15, 2015 $950,000 12% January 1, 2019. January 1, 2019. November 19, 2015 3,800,000 On April 1, 2015 $20,000 12% April 1, 2018. December 14, 2016. On October 15 , 2015 $980,000 12% January 1, 2019. January 1, 2019. November 19, 2015 3,920,000 On October 15 , 2015 $1,600,000 12% January 1, 2019. January 1, 2019. November 19, 2015 400,000 6,000,000 6,400,000 November 23, 2015 4,000,000 three December 17, 2015 2,000,000 fourth

Note 8 - Convertible Notes Paya

Note 8 - Convertible Notes Payable	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Convertible Debt Disclosure [Text Block]	NOTE 8: CONVERTIBLE NOTES PAYABLE The following table summarizes the convertible debt outstanding as of December 31, 2016. Principal at Carrying amount Date of Maturity Interest December 31, Short term Long term issuance date rate 2016 Related Non related Related Non related 3/26/1999 6/30/2004 10% $ 50,000 $ -0- $ 50,000 $ -0- $ -0- 8/29/2008 4/1/2018 10% 150,000 -0- -0- -0- 150,000 8/29/2008 4/1/2020 10% 1,770,000 -0- -0- 1,770,000 -0- 12/16/2008 4/1/2018 12% 200,000 -0- -0- -0- 200,000 12/16/2008 4/1/2020 12% 100,000 -0- -0- -0- 100,000 12/16/2008 4/1/2020 12% 4,055,000 -0- -0- 4,055,000 -0- 9/30/2009 4/1/2018 12% 100,000 -0- -0- -0- 100,000 9/30/2009 4/1/2020 12% 625,000 -0- -0- -0- 625,000 Total $ 7,050,000 $ -0- $ 50,000 $ 5,825,000 $ 1,175,000 The following table summarizes the convertible debt outstanding as of December 31, 2015. Principal at Carrying amount Date of Maturity Interest December 31, Short term Long term issuance date rate 2015 Related Non related Related Non related 3/26/1999 6/30/2004 10% $ 75,000 $ -0- $ 75,000 $ -0- $ -0- 8/29/2008 4/1/2017 10% 150,000 -0- -0- -0- 150,000 8/29/2008 4/1/2017 10% 1,770,000 -0- -0- 1,770,000 -0- 12/16/2008 4/1/2017 12% 260,000 -0- -0- -0- 260,000 12/16/2008 4/1/2017 12% 4,055,000 -0- -0- 4,055,000 -0- 12/16/2008 4/1/2018 12% 215,000 -0- -0- -0- 215,000 12/16/2008 4/1/2018 12% 25,000 -0- -0- 25,000 -0- 9/30/2009 4/1/2017 12% 625,000 -0- -0- -0- 625,000 9/30/2009 4/1/2018 12% 100,000 -0- -0- -0- 100,000 Total $ 7,275,000 $ -0- $ 75,000 $ 5,850,000 $ 1,350,000 10% During 1999 10% $862,500 There were costs of $119,625 $742,875. 10% June 30, 2004, $1.25 December 31, 2016, $812,500 1,495,179 $50,000. $88,210 December 31, 2016. Secured Convertible Debentures On September 30, 2009 $1,400,000 12% 5,600,000 $0.25 four four Chief Executive Officer and Director, Cornelis F. Wit (“Mr. Wit”). The Company received net proceeds of $1,400,000. 12% March 30, 2011. $0.25 On March 30, 2011 $200,000 $1,200,000 April 1, 2013, $1,100,000 Mr. Wit. The Company also extended the expiration date of the warrants associated with the September 2009 On February 22, 2013 and two $1,200,000 January 1, 2016, $1,100,000 September 2009 January 1, 2016. On January 31, 2015 $1,100,000 September 2009. 12% April 1, 2017. April 1, 2017. November 19, 2015 $475,000 1,900,000 November 19, 2015 1,900,000 $475,000 $475,000 1,900,000 November 23, 2015 $625,000 two On April 1, 2015 $100,000 to April 1, 2018. April 1, 2018. On June 30, 2016 two $625,000 April 1, 2020. April 1, 2020. Convertible Debentures August 2008 On August 29, 2008 $2,270,000 4,540,000 four Chief Executive Officer and Director, Cornelis F. Wit and one 10% August 29, 2010. $0.50 On September 30, 2009 two $1,920,000 August 29, 2013 On February 22, 2013 $1,770,000 f the convertible debentures to January 1, 2016. January 1, 2016. On February 22, 2013 $150,000 former Director, Guus van Kesteren (“Mr. van Kesteren”) to January 1, 2015. January 1, 2015. On April 21, 2014 the Company and Mr. van Kesteren, extended the maturity date of his $150,000 April 1, 2016. April 1, 2016. July 31, 2014 $150,000 On January 31, 2015 $1,770,000 April 1, 2017. April 1, 2017. On June 30, 2015 $150,000 o April 1, 2017. April 1, 2017. On June 30, 2016 $1,770,000 April 1, 2020. April 1, 2020. On June 30, 2016 $150,000 April 1, 2018. April 1, 2018. December 2008 On December 16, 2008 $5,075,000 10,150,000 eleven Chief Executive Officer and Director, Cornelis F. Wit (“Mr. Wit”), our Chief Operating Officer and President, Stephen E. Johnson (“Mr. Johnson”), our Chairman and Chief Technology Officer, Randall G. Smith (“Mr. Smith”), Chief Financial Officer, Ronald T. Linares, and four 12% December 16, 2010. $0.50 On September 30, 2009 seven $4,980,000 December 16, 2013 On February 22, 2013 $4,505,000 $4,475,000 Mr. Wit, $25,000 $5,000 January 1, 2016. January 1, 2016. On February 27, 2013 $15,000 , Matthew Veatch, to January 1, 2016. January 1, 2016. On March 6, 2013 der agreed to extend the maturity date of $200,000 January 1, 2014. January 1, 2014. On March 12, 2013 the holder agreed to extend the maturity date of $100,000 January 1, 2015. January 1, 2015. In December 2013 two agreed to extend the maturity date of $360,000, $160,000 January 1, 2016. January 1, 2016. July 31, 2014 $160,000 On April 28, 2014 the Company and the holder extended the maturity date of $100,000 December 2008. 12% April 1, 2016. April 1, 2016. On January 31, 2015 $4,475,000 December 2008. 12% April 1, 2017. April 1, 2017. November 19, 2015 $420,000 1,680,000 1,680,000 On April 27, 2015 $200,000 December 2008. 12% April 1, 2018. April 1, 2018. On April 30, 2015 $25,000 December 2008. 12% April 1, 2018. April 1, 2018. December 14, 2016. On May 1, 2015 $5,000 $5,000 December 2008. On May 1, 2015 Mr. van Kesteren extended the maturity date of $160,000 December 2008. 12% April 1, 2017. April 1, 2017. On May 7, 2015 the Company and our former Director, Matthew Veatch, extended the maturity date of $15,000 April 1, 2018. April 1, 2018. December 14, 2016. On June 30, 2015 the Company and the holder extended the maturity date of $100,000 December 2008. 12% April 1, 2017. April 1, 2017. On June 30, 2016 $4,055,000 April 1, 2020. April 1, 2020. On June 30, 2016 $160,000 April 1, 2018. April 1, 2018. The convertible debentures were repaid in full on December 14, 2016. On June 30, 2016 $100,000 April 1, 2020. April 1, 2020. December 2009 On December 31, 2009 $1,490,000 5,960,000 $0.25 four three Chief Executive Officer and Director, Cornelis F. Wit (“Mr. Wit”). The convertible debentures, which bear interest at 12% June 30, 2011. $0.25 On September 30, 2011 $1,490,000 October 1, 2013, $1,440,000 Mr. Wit. The Company also extended the expiration date of the warrants associated with the debentures to December 31, 2016. On February 22, 2013 $1,490,000 January 1, 2016, $1,440,000 Mr. Wit. The Company also extended the expiration date of the warrants associated with the debentures offering until January 1, 2016. On January 31, 2015 $1,440,000 April 1, 2017. April 1, 2017. November 19, 2015 $1,440,000 5,760,000 November 19, 2015 5,760,000 $1,440,000 5,760,000 On April 1, 2015 $50,000 December 2009. 12% April 1, 2018. December 7, 2015. The payments required at maturity under the Company’s outstanding convertible debt at December 31, 2016 2017 $ 50,000 2018 450,000 2019 -0- 2020 6,550,000 Total $ 7,050,000

Note 9 - Fair Value Measurement

Note 9 - Fair Value Measurement	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Fair Value Disclosures [Text Block]	NOTE 9 : FAIR VALUE MEASUREMENT The Company measures the fair value of its assets and liabilities under the guidance of ASC 820, 820 ASC 820 820 ● Level 1: ● Level 2: rvable either directly or indirectly such as quoted prices for similar assets or liabilities or market-corroborated inputs; and ● Level 3: assumptions about how market participants would price the assets or liabilities. The valuation techniques that may ● Market approach - Uses prices and other relevant information generated by market transactio ns involving identical or comparable assets or liabilities ● Income approach - Uses valuation techniques to convert future amounts to a single present amount based on current market expectations about those future amounts, including present value techniques , option-pricing models and excess earnings method ● Cost approach - Based on the amount that currently would be required to replace the service capacity of an asset (replacement cost) The Company also adopted the provisions of ASC 825, ASC 825 may December 31, 2016 December 31, 2015. The Company ’s financial assets or liabilities subject to ASC 820 December 31, 2016 2008 2009, 2011 2016 2013. 815 Disclosures about Derivative Instruments and Hedging Activities 8 Following is a description of the valuation methodologies used to determine the fair value of the Company ’s financial assets including the general classification of such instruments pursuant to the valuation hierarchy. A summary as of December 31, 2016 Fair value at Quoted prices in active markets for identical assets/ Significant other observable Significant unobservable December 31, 2016 liabilities (Level 1) inputs (Level 2) inputs (Level 3) Derivatives: (1) (2) Conversion feature liability $ 2,325,730 $ -0- $ -0- $ 2,325,730 Warrant liability 3,999,362 -0- -0- 3,999,362 Total of derivative liabilities $ 6,325,092 $ -0- $ -0- $ 6,325,092 (1) The fair value of the derivative instruments was estimated using the Income Approach and the Black Scholes option pricing model with the following assumptions for the year ended December 31, 2016 (2) The fair value at the measurement date is equal to the carrying value on the balance sheet Significant valuation assumptions for derivative instruments at December 31, 2016 Risk free interest rate 0.82% to 1.45% Dividend yield 0.00% Expected volatility 117.3% to 143.8% Expected life (range in years) Conversion feature liability 1.25 to 3.25 Warrant liability 0.25 to 3.25 A summary as of December 31, 2016 Carrying amount Carrying amount Quoted prices in active markets for identical assets/ Significant other observable Significant unobservable December 31, 2015 December 31, 2016 liabilities (Level 1) inputs (Level 2) inputs (Level 3) Acquired assets (3) Promasys B.V. customer list (4) $ 92,444 $ 82,173 $ -0- $ -0- $ 136,253 Promasys B.V. software code (4) 41,274 26,707 -0- -0- 72,943 Promasys B.V. URLs/website (4) 15,159 -0- -0- -0- 68,814 Total $ 148,877 $ 108,880 $ -0- $ -0- $ 278,010 (3) The fair value of the acquired assets was estimated using the Income Approach with a discounted cash flow valuation methodology applied. (4) The acquired Promasys B.V. software code, customer list and URLs/website are not measured on a recurring basis since their initial fair value has been deemed to have a finite life and is being amortized periodically. Instead the Company performs an impairment analysis on a quarterly basis in order to determine whether the carrying value of the assets reflects the fair value of the assets in a market based transaction. A summary as of December 31, 2015 Fair value at Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs December 31, 2015 (Level 1) (Level 2) (Level 3) Derivatives: (1) (2) Conversion feature liability $ 901,243 $ -0- $ -0- $ 901,243 Warrant liability 1,914,923 -0- -0- 1,914,923 Total of derivative liabilities $ 2,816,166 $ -0- $ -0- $ 2,816,166 (1) The fair value of the derivative instruments was estimated using the Income Approach and the Black Scholes option pricing model with the following assumptions for the year ended December 31, 2015 (2) The fair value at the measurement date is equal to the carrying value on the balance sheet ​ Significant valuation assumptions for derivative instruments at December 31, 2015 Risk free interest rate 0.48% to 1.2% Dividend yield 0.00% Expected volatility 91.0% to 132.2% Expected life (range in years) Conversion feature liability 1.25 to 2.25 Warrant liability 0.00 to 3.01 A summary as of December 31, 2015 Carrying Amount Carrying Amount Quoted prices in active markets for identical assets/ Significant other observable Significant unobservable December 31, 2014 December 31, 2015 liabilities (Level 1) inputs (Level 2) inputs (Level 3) Acquired assets (3) Promasys B.V. customer list (4) $ 110,948 $ 92,444 $ -0- $ -0- $ 136,253 Promasys B.V. software code (4) 55,842 41,274 -0- -0- 72,943 Promasys B.V. URLs/website (4) 37,131 15,159 -0- -0- 68,814 Total $ 203,921 $ 148,877 $ -0- $ -0- $ 278,010 (3) The fair value of the acquired assets was estimated using the Income Approach with a discounted cash flow valuation methodology applied. (4) The acquired Promasys B.V. software code, customer list and URLs/website are not measured on a recurring basis since their initial fair value has been deemed to have a finite life and is being amortized periodically. Instead the Company performs an impairment analysis on a quarterly basis in order to determine whether the carrying value of the assets reflects the fair value of the assets in a market based transaction. Other identifiable intangible assets, which are subject to amortization, are being amortized using the straight-line method over their estimated useful lives ranging from 3 15 may Other income/(expense) For the year ended December 31, 2016 December 31, 2015 The net amount of gains/(losses) for the period included in earnings attributable to the unrealized and realized gains/(losses) from changes in derivative liabilities at the reporting date $ (2,657,910 ) $ 4,525,798 Total unrealized and realized gains/(losses) included in earnings $ (2,657,910 ) $ 4,525,798 The tables below set forth a summary of changes in fair value of the Company ’s Level 3 December 31, 2016 December 31, 2015. 3 December 31, 2016 December 31, 2015. Level 3 financial liabilities at fair value Net purchases, Balance, issuances Balance, For the year ended beginning Net realized Net unrealized and Net transfers end December 31, 2016 of year gains/(losses) gains/(losses) settlements in and/or out of year Derivatives: Conversion feature liability $ (901,243 ) $ 29,108 $ (1,453,595 ) $ -0- $ -0- $ (2,325,730 ) Warrant liability (1,914,923 ) -0- (1,233,423 ) (851,016 ) -0- (3,999,362 ) Total of derivative liabilities $ (2,816,166 ) $ 29,108 $ (2,687,018 ) $ (851,016 ) $ -0- $ (6,325,092 ) Level 3 financial liabilities at fair value Net purchases, Balance, issuances Balance, For the year ended beginning Net realized Net unrealized and Net transfers end December 31, 2015 of year gains/(losses) gains/(losses) settlements in and/or out of year Derivatives: Conversion feature liability $ (2,944,402 ) $ 29,875 $ 2,013,284 $ -0- $ -0- $ (901,243 ) Warrant liability (6,695,060 ) -0- 2,482,639 (868,128 ) 3,165,626 (1,914,923 ) Total of derivative liabilities $ (9,639,462 ) $ 29,875 $ 4,495,923 $ (868,128 ) $ 3,165,626 $ (2,816,166 )

Note 10 - Commitments and Conti

Note 10 - Commitments and Contingencies	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	NOTE 1 0 : COMMITMENTS AND CONTINGENCIES The Company currently leases office space under operating leases for its office locations and has several operating leases related to server and network co-location and disaster recovery for its operations. The minimum future lease payments required under the Company’s operating leases at December 31, 2016 2017 $ 655,832 2018 512,157 2019 421,230 2020 297,570 2021 269,962 Thereafter 310,550 Total $ 2,467,301 In addition to annual base rental payments, the Company pays for the operating expenses associated with its leased office space and is responsible for any escalation in operating expenses as determined in the leases. Rent expense was $1,071,363 December 31, 2016 $972,862 December 31, 2015. The Company ’s corporate office lease expires in February 2023. March 2021. September 2017. July 2017. October 2018. LEGAL PROCEEDINGS From time to time the Company may December 31, 2016, PATENT LITIGATION SETTLEMENT Effective April 2, 2009, June 18, 2008 6,496,827 B2 , and (ii) released us from any and all claims of infringement of the Licensed Patent which may may January 1, 2008 May 12, 2018 two (2%) 2017 $450,000 may 1,000,000 $.01 second April 2, 2011, May 12, 2018. $300,000 The remaining minimum royalty payments per year are as follows: 2017 $ 450,000 2018 164,500 Total $ 614,500 On June 23, 2009, Concurrent with the consummation of that transaction we entered into the First Amendment to Settlement and Licensing Agreement with DataSci, (i) to include the eResearch Technology EDC assets acquired within the definition of Licensed Products, and as such subject to the royalty payment(s), under and in accordance with the Settlement and Licensing Agreement, and (ii) provide a release by DataSci of any and all claims of infringement of the Licensed Patent in connection with the eResearch Technology EDC assets acquired which may $300,000. The Company recorded a charge to earnings of $94,129 December 31, 2016 $244,747 December 31, 2015, (1) December 31, 2016 December 31, 2015 (2) EMPLOYMENT AGREEMENTS The Company has employment agreements in place with the following members of our executive management team: Cornelis F. Wit, Chief Executive Officer Randall G. Smith, Chief Technology Officer Stephen E. Johnson, President and Chief Operating Officer The employment agreements provide, among other things, for participation in employee benefits available to employees and executives. Each of the agreements will renew for successive one ninety may ’s employment upon 30 may

Note 11 - Related Party Transac

Note 11 - Related Party Transactions	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	NOTE 1 1 : RELATED PARTY TRANSACTIONS On April 1, 2015 $20,000 (“Mr. Smith”), in exchange for an existing promissory note in the same amount. The promissory note carries an interest rate of 12% April 1, 2018. December 14, 2016. On April 30, 2015, $25,000 December 2008. 12% April 1, 2018. April 1, 2018. The convertible debentures were repaid in full on December 14, 2016. On May 1, 2015 $5,000 Mr. Smith in exchange for an outstanding convertible note in the same amount. The note carried an interest rate of 12% January 1, 2016. As of December 31, 2016, $5,825,000 $450,000 ● In June 2008, $510,000 August 29, 2008, $510,000 $1,260,000 3,540,000 10% August 29, 2010. $0.50 September 30, 2009, $1,770,000 August 29, 2013 February 22, 2013, $1,770,000 January 1, 2016. January 1, 2016. January 31, 2015 $1,770,000 April 1, 2017. April 1, 2017. June 30, 2016 $1,770,000 April 1, 2020. April 1, 2020. ● In February 2008, $150,000 September 2008 December 2008, $4,200,000 December 16, 2008, $4,350,000 8,700,000 12% December 16, 2010. $0.50 September 30, 2009, $4,350,000 December 16, 2013 October 16, 2012, $125,000 December 2008 250,000 February 22, 2013, $4,475,000 January 1, 2016. January 1, 2016. January 31, 2015 $4,475,000 April 1, 2017. April 1, 2017. November 19, 2015 $420,000 1,680,000 1,680,000 . On June 30, 2016 $4,055,000 April 1, 2020. April 1, 2020. ● From July 2009 September 2009, $1,100,000 one September 30, 2009. September 30, 2009, 12% March 30, 2011. 4,400,000 4,400,000 $0.25. March 30, 2011, April 1, 2013 4,400,000 two September 30, 2015. February 22, 2013, January 1, 2016 January 1, 2016. January 31, 2015 $1,100,000 April 1, 2017. April 1, 2017. November 19, 2015 $475,000 1,900,000 November 19, 2015 1,900,000 $475,000 $475,000 1,900,000 November 23, 2015 $625,000 two . ● From October 2009 December 2009, $1,440,000, one December 31, 2009. December 31, 2009, 12% June 30, 2011. October 1, 2013 5,760,000 two December 31, 2015. February 22, 2013, January 1, 2016 January 1, 2016. January 31, 2015 $1,440,000 April 1, 2017. April 1, 2017. November 19, 2015 $1,440,000 5,760,000 November 19, 2015 5,760,000 $1,440,000 5,760,000 ● On January 1, 2014, $980,000 3,920,000 $0.25 April 1, 2017 $980,000. 12% April 1, 2017. October 15, 2015 $980,000 12% January 1, 2019. January 1, 2019. November 19, 2015 3,920,000 ● On January 31, 2015 $2,860,000 $6,879 12% April 1, 2017. April 1, 2017. October 15, 2015 $2,860,000 12% January 1, 2019. January 1, 2019. November 19, 2015 11,440,000 11,440,000 . ● On January 31, 2015 $529,000 12% April 1, 2017. April 1, 2017. October 15, 2015 $529,000 12% January 1, 2019. January 1, 2019. November 19, 2015 2,116,000 ● On January 31, 2015, $950,000 3,800,000 $0.25 April 1, 2017 $280,000 $670,000. 12% April 1, 2017. October 15, 2015 $950,000 12% January 1, 2019. January 1, 2019. November 19, 2015 3,800,000 . ● On November 19, 2015 37,023,517 $6,919,000 12% $420,000 12% 29,363,517 $0.25 $1,915,000 $0.25 ● On February 29, 2016, $450,000 1,800,000 $0.25 April 1, 2019 $450,000. 12% April 1, 2019. On March 18, 2013, $2,000,000 guaranteed by Mr. Wit. On December 18, 2013 $4,000,000. February 3, 2015 $5,000,000. 2.0% $9,500 February 2, 2018 December 31, 2016, $2,700,000 2.75%. The Company incurred interest expense payable to related parties of $918,189 year ended December 31, 2016 $2,434,101 year ended December 31, 2015.

Note 12 - Stockholders' (Defici

Note 12 - Stockholders' (Deficit)	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	NOTE 1 2 : STOCKHOLDERS’ (DEFICIT) Our authorized capital stock consists of 500,000,000 $.001 10,000,000 $.001 5,000,000 5% 230,000 747,500 250,000 As of December 31, 2016 ● 1 47,786,917 ● 2 7 ,86 0,000 ● - 0 shares of our Series A Preferred Stock issued and outstanding; ● - 0 Preferred Stock issued and outstanding; ● - 0 Preferred Stock issued and outstanding; ● 250,000 ● $ 7 ,05 0,000 15,490,000 Common Stock Holders of common stock are entitled to one Holders of our voting securities do not have cumulative voting rights. Holders of common stock are entitled to share in all dividends that the Board of Directors, in its discretion, declares from legally available funds. In the event of our liquidation, dissolution or winding up each outstanding share of common stock entitles its holder to participate in all assets that remain after payment of liabilities and after providing for each class of stock, if any, having preference over the common stock. Holders of common stock have no conversion, preemptive or other subscription rights, and there are no redemption provisions for the common stock. The rights of the holders of common stock are subject to any rights that may On March 20, 2015 665,000 2009 3 On March 23, 2015 7,500 On April 29, 2015 5,800 On June 11, 2015 360,000 2009 3 On June 15, 2015 225,000 On June 30, 2015 20,000 On July 17, 2015 66,668 ’s service. On August 21, 2015 1,628 On October 16, 2015 50,002 On November 19, 2015 37,023,517 Cornelis F. Wit, our Chief Executive Officer and Director. The shares were issued in exchange (i) for the cancellation of $6,919,000 12% $420,000 12% 29,363,517 $0.25 $1,915,000 $0.25 On December 31, 2015 four 5% 487,500 1,950,000 During the first four 2016 14,615,696 On A pril 13, 2016 3,012 On A pril 25, 2016 1,000,000 On A pril 26, 2016 1,594 On June 1 6, 2016 360,000 2009 3 On July 20, 2016 3,038 On December 30, 2016 2011. 100,000 The 2009 1 3, Preferred stock Our Board of Directors, without further stockholder approval, may one may ● dividend and liquidation preferences, ● voting rights, ● conversion privileges, and ● redemption terms. Our Board of Directors may In addition, our Board of Directors can fix limitations and restrictions, if any, upon the payment of dividends on our common stock to be effective while any shares of preferred stock are outstanding. The following table presents the cumulative arrearage of undeclared dividends by class of preferred stock as of December 31, 2016 December 31, 2015 Cumulative arrearage as of Cumulative arrearage per share as of December 31, December 31, Series of preferred stock 2016 2015 2016 2015 Series A $ -0- $ 2,465,830 $ -0- $ 0.68 Series B 609,887 609,887 $ 3.05 $ 3.05 Series C 1,472,093 1,472,093 $ 4.37 $ 4.37 Total preferred stock arrearage $ 2,081,980 $ 4,547,810 Series A Preferred Stock In 1999, 5,000,000 5% - 0 The designations, rights and preferences of the Series A Preferred include: ● the shares are not redeemable, ● each share of Series A Preferred Stock is convertible into shares of our common stock at any time at the option of the holder at a conversion price of $1. 11 one $3.00 20 ● the conversion price has certain anti-dilution protections for any stock splits, stock dividends, and corporate reorganizations, and certain other corporate transactions and issuances of securities at below the applicable conversion price per share. The Series A Preferred Stockholders have waived their rights to an anti-dilution adjustment reducing their conversion price as a result of the issuance of the Series B Preferred Stock and Series C Preferred Stock, ● the shares of Series A Preferred Stock pay a cumulative dividend at a rate of 5% $1.00 At our option, dividends can be paid in cash or shares of common stock valued at the conversion price of the Series A Preferred Stock, ● in the event of our liquidation or winding up, each share of Series A Preferred Stock has a liquidation preference equal to $1.00 and ● the holders of the Series A Preferred Stock are entitled to vote together with the holders of our common stock, on the basis of one In addition, the holders of the Series A Preferred Stock were granted certain demand and piggy-back registration rights for the shares of our common stock issuable upon the conversion of the Series A Preferred Stock. There were cumulative arrearages of $ - 0 $2,465,830, $0.00 $0.68 December 31, 2016 December 31, 2015 Prior to 2015 235,000 5% In December 2015 34 Series A Preferred Shareholders. The terms of the exchange offer were 4 December 31, 2015 four 5% 487,500 1,950,000 first 4 2016, 3,637,724 14,615,696 Series B Preferred Stock In August 2001, 200,000 February 7, 2002 230,000 0 The designations, rights and preferences of the Series B Preferred Stock include: ● the stated value of each share is $10.00 ● the shares are not redeemable, ● each share of Series B Preferred Stock is convertible into shares of our common stock at the option of the holder at any time commencing January 31, 2002 $0.25 $0.25 $25 $0.75 We may $0.50 20 ● the conversion price has certain anti-dilution protections for any stock splits, stock dividends, and corporate reorganizations, and certain other corporate transactions and issuances of securities at below the applicable conversion price per share or market value of the common stock, ● the shares of Series B Preferred Stock pay a cumulative dividend at a rate of 8% $10.00 At our option, dividends can be paid in cash or shares of common stock valued at the conversion price of the Series B Preferred Stock, ● each share of Series B Preferred Stock will rank senior to our Series A Preferred and pari passu with our Series C Preferred Stock, ● in the event of our liquidation or winding up, each share of Series B Preferred Stock has a liquidation preference equal to $10.00 ● the holders of the Series B Preferred Stock are entitled to vote, together with the holders of our common stock, on the basis of one There were cumulative arrearages of $609,887 $609,887, $3.05 $3.05 December 31, 2016 December 31, 2015, The Company has 200,000 Pursuant to Delaware General Corporate Law, once the Company has a positive net worth, the cumulative dividends would be payable in either cash or in shares of our common stock upon the declaration of dividends by our board of directors. In addition, the holders of the Series B Preferred Stock were granted certain mandatory and piggy-back registration rights for the shares of our common stock issuable upon the conversion of the Series B Preferred Stock and are entitled to vote one Series C Preferred Stock In March 2002, 747,500 0 The designations, rights and preferences of the Series C Preferred Stock include: ● the stated value of each share is $10.00 ● the shares are not redeemable, ● each share of Series C Preferred Stock is convertible at any time, at the option of the holder, into a number of shares of common stock determined by dividing the stated value per share of the Series C Preferred Stock by $0.25, The Series C Preferred Stock will automatically convert, subject to limitations based on trading volume, into shares of our common stock upon a public offering of our securities raising gross proceeds in excess of $25,000,000 2.5 two 20 30 10 20 ● the conversion price has certain anti-dilution protections for any stock splits, stock dividends, and corporate reorganizations, and certain other corporate transactions and issuances of securities at below the applicable conversion price per share or market value of the common stock, ● the shares of Series C Preferred Stock pay a cumulative dividend at a rate of 8% $10.00 At our option, dividends can be paid in cash or shares of common stock valued at the conversion price of the Series C Preferred Stock, ● each share of Series C Preferred Stock will rank pari passu with our Series B Preferred Stock and senior to our Series A Preferred Stock, ● in the event of our liquidation or winding up, each share of Series C Preferred Stock has a liquidation preference equal to $10.00 ● the holders of the Series C Preferred Stock are entitled to vote, together with the holders of our common stock, on the basis of one There were cumulative arrearages of $1,472,093 $1,472,093, $4.3 7 $4.37 December 31, 2016 December 31, 2015, The Company has 337,150 Pursuant to Delaware General Corporate Law, once the Company has a positive net worth, the cumulative dividends would be payable in either cash or in shares of our common stock upon the declaration of dividends by our board of directors. In addition, the holders of the Series C Preferred Stock were granted certain mandatory and piggy-back registration rights covering the shares of our common stock issuable upon the conversion of the Series C Preferred Stock and are entitled to vote two Series D Preferred Stock In November 2010, 250,000 250,000 The designations, rights and preferences of the Series D Preferred Stock include: ● the stated value of the Series D Preferred is $0.001 ● the Series D Preferred has no rights to receive dividend distributions or to participate in any dividends declared by the Corporation to or for the benefit of the holders of its common stock, ● the shares of Series D Preferred are not convertible into or exchangeable for any ot her security of the Corporation, ● except as provided in Series D Preferred Designation, in the case of the death or disability of Series D Preferred holder, the Series D Preferred is not redeemable without the prior express written consent of the holders of the majority of the voting power of all then outstanding shares of such Series D Preferred. In the event any shares of Series D Preferred are redeemed pursuant, the shares redeemed will automatically be canceled and returned to the status of authorized but uni ssued shares of preferred stock, ● each share of Series D Preferred entitles the holder to four (400) ● in the event of the liquidation, dissolution or winding up of the affairs of the Corporation, whether voluntary or involuntary, the holders of shares of the Series D Preferred then outstanding are entitled to receive before holders of shares of common stock receive any amounts, out of the remaining assets of the Corporation available for distribution to its stockholders, an amount equal to $0.001 r share, ● so long as any shares of Series D Preferred are outstanding, the Company cannot without first res of Series D Preferred Stock, ● the holders of the Series D Preferred are not entitled to rights to subscribe for, purchase or receive any part of any new or additional shares of any class, whether now or hereinafter authorized, or of bonds or debentures, or other evidences of indebtedness convertible into or exchangeable for shares of any class, ● the Company has a thirty (30) first The Company must purchase all of those shares of Series D Preferred offered by the holder of the Series D Preferred Stock, and ● the holders of Series D Preferred cannot, directly or indirectly, transfer any shares of Series D Preferred. Any such purported transfer shall be of no force or effect and shall not be recognized by the Company. The following table presents preferred dividends accreted for the years ended December 31, 2016 December 31, 2015, Dividends accreted Dividends per share For the year ended For the year ended December 31, December 31, 2016 2015 2016 2015 Preferred stock dividends in arrears Series A $ -0- $ 181,886 $ -0- $ 0.050 Preferred stock dividends in arrears Series B $ -0- $ -0- $ -0- $ -0- Preferred stock dividends in arrears Series C $ -0- $ -0- $ -0- $ -0- Warrants Issued for Services and in Capital Transactions The following tables summarize all warrants issued as part of debt transactions for the year ended December 31, 2016 December 31, 2015, December 31, 2016 December 31, 2016 Warrants outstanding Warrants exercisable Weighted average Weighted average Weighted average Range of exercise price Number outstanding remaining contractual life exercise price Number exercisable exercise price $0.25 - $0.60 27,860,000 2.71 $ 0.42 27,860,000 $ 0.42 December 31, 2015 December 31, 2015 Warrants outstanding Warrants exercisable Weighted average Weighted average Weighted average Range of exercise price Number outstanding remaining contractual life exercise price Number exercisable exercise price $0.25 - $0.60 22,900,000 1.76 $ 0.46 22,900,000 $ 0.46 Warrants Balance at December 31, 2014 48,463,517 Issued 3,800,000 Exercised -0- Cancelled (29,363,517 ) Expired/forfeited -0- Balance at December 31, 2015 22,900,000 Issued 4,970,000 Exercised -0- Expired/forfeited (10,000 ) Balance at December 31, 2016 27,860,000 Warrants exercisable at December 31, 2016 27,860,000 Weighted average fair value of warrants granted during 2016 $ 0.16 Other Comprehensive (Loss) Due to the availability of net operating losses and related deferred tax valuations, there is no tax effect associated with any component of other comprehensive (loss). The following table lists the beginning balance, yearly activity and ending balance of the components of accumulated other comprehensive (loss). Foreign currency translation Accumulated other comprehensive (loss) Balance at December 31, 2014 $ (243,827 ) $ (243,827 ) 2015 Activity (122,528 ) (122,528 ) Balance at December 31, 2015 (366,355 ) (366,355 ) 2016 Activity (44,150 ) (44,150 ) Balance at December 31, 2016 $ (410,505 ) $ (410,505 )

Note 13 - Employee Equity Incen

Note 13 - Employee Equity Incentive Plans	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	NOTE 1 3 : EMPLOYEE EQUITY INCENTIVE PLANS Stock Option Plans Description of 2016 In 2016, ’s Board of Directors and stockholders approved the OmniComm Systems, Inc. 2016 “2016 2016 2016 10,000,000 2016 2016 January 1st nine (9) January 1, 2017 January 1, 2025, five (5%) 2016 2016 June 29, 2026. The maximum term for any option grant under the 2016 ten 2016 five two first 50% one second second three Any unvested stock options or restricted shares with restrictions that have not lapsed that are granted under the 2016 As of December 31, 2016, 450,000 0 2016 December 31, 2016, 9,550,000 2016 Description of 2009 In 2009, ’s Board of Directors and stockholders approved the 2009 “2009 2009 2009 7,500,000 The maximum term for any option grant under the 2009 ten 2009 five Options granted to employees generally vested either upon grant or in two first 50% one second second 2009 2016 2009 As of December 31, 2016, 775,000 3,893,330 2009 December 31, 2016, 0 2009 The following table summarizes the stock option activity for the Company ’s equity incentive plans: Number of options Weighted average exercise price (per share) Weighted average remaining contractual term (in years) Aggregate intrinsic value Outstanding at December 31, 2014 3,130,000 $ 0.20 1.59 $ 364,900 Granted 225,000 0.25 Exercised (292,500 ) 0.12 Forfeited/cancelled/expired (1,060,000 ) 0.35 Outstanding at December 31, 2015 2,002,500 0.14 1.40 $ 198,990 Granted 450,000 0.20 Exercised (1,120,000 ) 0.12 Forfeited/cancelled/expired (107,500 ) 0.29 Outstanding at December 31, 2016 1,225,000 $ 0.17 2.62 $ 83,425 Vested and exercisable at December 31, 2016 737,500 $ 0.15 1.38 $ 64,550 The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the Company ’s closing stock price at fiscal year-end and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December 31, 2016. The total number of shares vested and the fair value of shares vested for the years ended December 31, 2016 December 31, 2015, Fair value of options vesting for the year ended Number of options vested Fair value of options vested December 31, 2016 162,500 $ 33,622 December 31, 2015 200,000 $ 34,665 Cash received from stock option exercises for the years ended December 31, 2016 December 31, 2015 $129,500 $27,250, December 31, 2016 December 31, 2015. The following table summarizes information concerning options outstanding at December 31, 2016: Awards breakdown by price range at December 31, 2016 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 850,000 2.15 $ 0.15 625,000 1.32 $ 0.14 0.21 to 0.29 375,000 3.70 0.23 112,500 1.67 0.21 0.30 to 0.49 -0- 0.00 0.00 -0- 0.00 0.00 0.50 to 0.70 -0- 0.00 0.00 -0- 0.00 0.00 0.00 to 0.70 1,225,000 2.62 $ 0.17 737,500 1.38 $ 0.15 The following table summarizes information concerning options outstanding at December 31, 2015: Awards breakdown by price range at December 31, 2015 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 1,777,500 1.14 $ 0.13 1,652,500 0.93 $ 0.13 0.21 to 0.29 125,000 2.83 0.22 100,000 2.46 0.21 0.30 to 0.49 100,000 4.17 0.30 -0- 0.00 0.00 0.50 to 0.70 -0- 0.00 0.00 -0- 0.00 0.00 0.00 to 0.70 2,002,500 1.40 $ 0.14 1,752,500 1.02 $ 0.13 The weighted average fair value (per share) of options granted during the years ended December 31, 2016 December 31, 2015 $0.19 $0.24, Basis for Fair Value Estimate of Share-Based Payments Based on analysis of its historical volatility, the Company expects that the future volatility of its share price is likely to be similar to the historical volatility the Company experienced since the Company ’s commercialization activities were initiated during the second 2000. 2016 2015. may The Company utilizes the historical data available regarding employee and director exercise activity to calculate an expected life of the options. The table below presents the weighted average expected life in years of options granted under the Plan as described above. The risk-free rate of the stock options is based on the U.S. Treasury yield curve in effect at the time of grant, which corresponds with the expected term of the option granted. The fair value of share-based payments was estimated using the Black Scholes option pricing model with the following assumptions for grants made during the periods indicated. Stock option assumptions for the year ended Stock option assumptions December 31, 2016 December 31, 2015 Risk-free interest rate 1.45% 1.20% Expected dividend yield 0.0% 0.0% Expected volatility 155.5% 183.8% Expected life of options (in years) 5 5 The following table summarizes weighted average grant date fair value activity for the Company incentive stock plans: Weighted average grant date fair value for the year ended December 31, 2016 2015 Stock options granted during the period $ 0.19 $ 0.24 Stock options vested during the period $ 0.21 $ 0.17 Stock options forfeited during the period $ 0.28 $ 0.26 A summary of the status of the Company ’s non-vested shares underlying stock options as of December 31, 2016, December 31, 2016 Shares underlying stock options Weighted average grant date fair value Nonvested shares at 250,000 $ 0.23 Nonvested shares at 487,500 $ 0.20 As of December 31, 2016, $76,846 2.38

Note 14 - Income Taxes

Note 14 - Income Taxes	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Income Tax Disclosure [Text Block]	NOTE 1 4 : INCOME TAXES A reconciliation of income tax expense and the amount computed by applying the statutory federal income tax rate to the income before provision for income taxes is as follows : December 31, 2016 December 31, 2015 Federal statutory rate applied to income/(loss) before income taxes $ 38,740 $ 963,947 Increase/(decrease) in income taxes results from: Current tax expense/(benefit) 1,069 (24,739 ) Nondeductible expenses 1,078,519 (1,451,221 ) Change in deferred assets 41,019 97,580 Change in valuation allowance (1,158,278 ) 389,694 Income tax expense/(benefit) $ 1,069 $ (24,739 ) The components of income tax expense/(benefit) for the year ended: December 31, 2016 December 31, 2015 Current tax expense/(benefit): $ 1,069 $ (24,739 ) Deferred tax expense/(benefit): Bad debt allowance (23,699 ) 26,059 Operating loss carryforward 1,140,957 (513,333 ) Amortization of intangibles 5,482 5,482 Patent litigation settlement 35,538 92,098 1,159,347 (414,433 ) Valuation allowance (1,158,278 ) 389,694 Total tax expense/(benefit) $ 1,069 $ (24,739 ) Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax assets and liabilities are as follows: December 31, 2016 December 31, 2015 Amortization of intangibles $ 267,253 $ 272,734 Bad debt allowance 66,662 42,963 Patent litigation liability accrual 128,804 164,342 Operating loss carryforwards 19,034,573 20,175,531 Gross deferred tax assets 19,497,292 20,655,570 Valuation allowance (19,497,292 ) (20,655,570 ) Net deferred tax liability/(asset) $ -0- $ -0- The Company has net operating loss carry forwards (NOL) for income tax purposes of $ 35,363,091. 2036 1998. December 31, 2016. December 31, 2016 $1,158,278. three

Note 15 - Subsequent Events

Note 15 - Subsequent Events	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Subsequent Events [Text Block]	NOTE 1 5 : SUBSEQUENT EVENTS Subsequent to December 31, 2016 $400,000 On March 24, 2017 500,000 three four 2017. 2016 $0.25 March 24, 2022. On March 24, 2017 16,668

Significant Accounting Policies

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2016
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION The Company ’s accounts include those of all its wholly-owned subsidiaries and have been prepared in conformity with (i) accounting principles generally accepted in the United States of America; and (ii) the rules and regulations of the United States Securities and Exchange Commission. All significant intercompany accounts and transactions between the Company and its subsidiaries have been eliminated in consolidation.
Use of Estimates, Policy [Policy Text Block]	ESTIMATES IN FINANCIAL STATEMENTS The preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Significant estimates incorporated in our financial statements include the recorded allowance for doubtful accounts, the estimate of the appropriate amortization period of our intangible assets, the evaluation of whether our intangible assets have suffered any impairment, the allocation of revenues under multiple-element customer contracts, royalty-based patent liabilities, the value of derivatives associated with debt issued by the Company and the valuation of any corresponding discount to the issuance of our debt. Actual results may
Reclassification, Policy [Policy Text Block]	RECLASSIFICATIONS Certain reclassifications have been made in the 2015 2016
Foreign Currency Transactions and Translations Policy [Policy Text Block]	FOREIGN CURRENCY TRANSLATION The financial statements of the Company ’s foreign subsidiaries are translated in accordance with ASC 830 30, Foreign Currency Matters—Translation of Financial Statements $44,150 December 31, 2016 $122,528 December 31, 2015.
Revenue Recognition, Policy [Policy Text Block]	REVENUE RECOGNITION POLICY The Company derives revenues from software licenses and services of its EDC products and services which can be purchased on a stand-alone basis. License revenues are derived principally from the sale of term licenses for the following software products offered by the Company: TrialMaster, TrialOne , Promasys eClinical Suite ( “EDC Software”). TrialMaster eClinical Suite The Company recognizes revenues when all of the following conditions are satisfied: (1) there is persuasive evidence of an arrangement; (2) (3) (4) The Company operates in one The Company segregates its revenues based on the activity cycle used to generate its revenues. Accordingly, revenues are currently generated through four Hosted Application Revenues The Company offers its TrialMaster eClinical Suite Revenues resulting from TrialMaster eClinical Suite three first second third Fees charged and costs incurred for the trial system design, set up and implementation are amortized and recognized ratably over the estimated hosting period. Work performed outside the original scope of work is contracted for separately as an additional fee and is generally recognized ratably over the remaining term of the hosting period. Fees for the first third second eClinical Suite Licensing Revenues The Company's software license revenues are earned from the sale of off-the-shelf software. From time-to-time a client might require significant modification or customization subsequent to delivery to the customer. The Company generally enters into software term licenses for its EDC Software products with its customers for 3 5 30 45 In the past the Company has sold perpetual licenses for EDC Software products in certain situations to existing customers with the option to purchase customer support, and may The Company generates customer support and maintenance revenues from its perpetual license customer base. Professional Services The Company may Subsequent additions or extensions to license terms do not generally include additional professional services. Maintenance Revenues Maintenance includes telephone-based help desk support and software maintenance. The Company generally bundles customer support with the software license for the entire term of the arrangement. As a result, the Company generally recognizes revenues for both maintenance and software licenses ratably over the term of the software license and support arrangement. The Company allocates the revenues recognized for these arrangements to the different elements based on management's estimate of the relative fair value of each element. The Company generally invoices each of the elements based on separately quoted amounts and thus has a fairly accurate estimate of the relative fair values of each of the invoiced revenue elements. The fees associated with each business activity for the years ended December 31, 2016 December 31, 2015, For the year ended Revenue activity December 31, 2016 December 31, 2015 Set-up fees $ 6,658,987 $ 6,649,762 Change orders 1,212,153 846,464 Maintenance 4,803,171 5,107,764 Software licenses 7,885,023 3,975,549 Professional services 3,843,641 3,145,883 Hosting 1,016,535 985,415 Total $ 25,419,510 $ 20,710,837
Cost of Sales, Policy [Policy Text Block]	COST OF GOODS SOLD Cost of goods sold primarily consists of costs related to hosting, maintaining and supporting the Company ’s application suite and delivering professional services and support. These costs include salaries, benefits, bonuses and stock-based compensation for the Company’s professional services staff. Cost of goods sold also includes outside service provider costs .
Cash and Cash Equivalents, Policy [Policy Text Block]	CASH AND CASH EQUIVALENTS Cash equivalents consist of highly liquid, short-term investments with maturities of 90 The carrying amount reported in the accompanying consolidated balance sheets approximates fair value.
Receivables, Policy [Policy Text Block]	ACCOUNTS RECEIVABLE Accounts receivable are judged as to collectability by management and an allowance for bad debts is established as necessary. The allowance is based on an evaluation of the collectability of accounts receivable and prior bad debt experience. The Company had recorded an allowance for uncollectible accounts receivable of $179,813 December 31, 2016 $116,834 December 31, 2015. The following table summarizes activity in the Company's allowance for doubtful accounts for the years presented. December 31, 2016 December 31, 2015 Beginning of period $ 116,834 $ 186,085 Bad debt expense 132,767 14,939 Write-offs (69,788 ) (84,190 ) End of period $ 179,813 $ 116,834
Concentration Risk, Credit Risk, Policy [Policy Text Block]	CONCENTRATION OF CREDIT RISK Cash and cash equivalents and restricted cash are deposited with major financial institutions and, at times, such balances with any one may December 31, 2016, $1,237,118 Except as follows, the Company has no significant off balance sheet risk or credit risk concentrations. Financial instruments that subject the Company to potential credit risks are principally cash equivalents and accounts receivable. Concentrated credit risk with respect to accounts receivable is limited to creditworthy customers. The Company's customers are principally located in the United States, Europe and East Asia. The Company is directly affected by the overall financial condition of the pharmaceutical, biotechnology and medical device industries and management believes that credit risk exists and that any credit risk the Company faces has been adequately reserved for as of December 31, 2016. December 31, 2016, One customer accounted for 16% December 31, 2016 $4,167,000, 16% December 31, 2015 $3,237,000. 10% Two customers each individually accounted for approximately 11% December 31, 2016. 16% December 31, 2015. Revenues Accounts receivable For the year ended Number of customers Percentage of total revenues Number of customers Percentage of accounts receivable December 31, 2016 1 16% 2 21% December 31, 2015 1 16% 3 42% The table below provides revenues from European customers for the years ended December 31, 2016 December 31, 2015, European revenues For the year ended December 31, 2016 December 31, 2015 European revenues % of Total revenues European revenues % of Total revenues $ 2,702,660 11% $ 2,150,096 10% The Company serves all of its hosting customers from third third may
Property, Plant and Equipment, Policy [Policy Text Block]	PROPERTY AND EQUIPMENT Property and equipment are recorded at cost. Additions and betterments are capitalized; maintenance and repairs are expensed as incurred. Depreciation is calculated using the straight-line method over the asset’s estimated useful life, which is 5 3
Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]	ASSET IMPAIRMENT Acquisitions and Intangible Assets We account for acquisitions in accordance with ASC 805, Business Combinations 805”) 350, Intangibles- Goodwill and Other 350”). The judgments that we make in determining the estimated fair value assigned to each class of assets acquired and liabilities assumed, as well as asset lives, can materially impact net income in periods following an asset acquisition. We generally use either the income, cost or market approach to aid in our conclusions of such fair values and asset lives. The income approach presumes that the value of an asset can be estimated by the net economic benefit to be received over the life of the asset, discounted to present value. The cost approach presumes that an investor would pay no more for an asset than its replacement or reproduction cost. The market approach estimates value based on what other participants in the market have paid for reasonably similar assets. Although each valuation approach is considered in valuing the assets acquired, the approach ultimately selected is based on the characteristics of the asset and the availability of information. Long-lived Assets We review long-lived assets for impairment whenever events or changes in circumstances indicate that the related carrying amounts may ’s residual value, if any. In turn, measurement of an impairment loss requires a determination of fair value, which is based on the best information available. We use quoted market prices when available and independent appraisals and management estimates of future operating cash flows, as appropriate, to determine fair value.
Revenue Recognition, Deferred Revenue [Policy Text Block]	DEFERRED REVENUE Deferred revenue represents cash advances received in excess of revenue earned on on-going contracts. Payment terms vary with each contract but may December 31, 2016, $9,539,230 1 5 $7,250,061 twelve
Advertising Costs, Policy [Policy Text Block]	ADVERTISING Advertising costs are expensed as incurred. Advertising costs were $712,179 December 31, 2016 $635,267 December 31, 2015
Research, Development, and Computer Software, Policy [Policy Text Block]	RESEARCH AND PRODUCT DEVELOPMENT EXPENSES Software development costs are included in research and product development and are expensed as incurred. ASC 985.20, 985.20. December 31, 2016 $2,598,962 December 31, 2015 $2,639,577, activities, which include costs associated with the development of our software products and services for our client’s projects and which are primarily comprised of salaries and related expenses for our software developers and consulting fees paid to third costs are primarily included under Salaries, benefits and related taxes in our Statement of Operations.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	EMPLOYEE EQUITY INCENTIVE PLANS The OmniComm Systems, Inc. 2016 “2016 June 16, 2016. The 2016 10,000,000 2016 January 1st nine (9) January 1, 2017 January 1, 2025, five (5%) 2016 The predecessor plan, the OmniComm Systems, Inc. 2009 “2009 July 10, 2009 June 16, 2016 2016 The 2009 7.5 2009 Each plan is more fully described in “Note 13, ASC 718, ASC 718 ’s consolidated statements of operations. The Company currently uses the Black Scholes option pricing model to determine grant date fair value.
Earnings Per Share, Policy [Policy Text Block]	EARNINGS/(LOSS) PER SHARE The Company accounts for Earnings/(loss) Per Share using ASC 260 – Earnings per Share. Unlike diluted earnings per share, basic earnings per share excludes any dilutive effects of options, warrants, and convertible securities.
Income Tax, Policy [Policy Text Block]	INCOME TAXES The Company accounts for income taxes in accordance with ASC 740, 740 Valuation allowances are established, when necessary, to reduce deferred tax assets to the estimated amount to be realized. Income tax expense represents the tax payable for the current period and the change during the period in the deferred tax assets and liabilities.
New Accounting Pronouncements, Policy [Policy Text Block]	IMPACT OF NEW ACCOUNTING STANDARDS During fiscal 2016, In February 2016, ASU”) No. 2016 02, “Leases (Topic 842)” 2016 02”). 12 December 15, 2019. In March 2016, ASU No. 2016 09, “Compensation – Stock Compensation (Topic 718)”, 2016 09”). December 15, 2016, In March 2016, April 2016, December 2016, 2016 08, Revenue from Contracts with Customers - Principal versus Agent Considerations (Reporting Revenue Gross versus Net) 2016 08”), 2016 10, Revenue from Contracts with Customers - Identifying Performance Obligations and Licensing 2016 10”), 2016 20, Technical Corrections and Improvements to Topic 606, 2016 20”) 2014 09. May 2016, 2016 12, Revenue from Contracts with Customers - Narrow Scope Improvements and Practical Expedients 2014 09, December 15, 2016, Accounting standards-setting organizations frequently issue new or revised accounting rules. We regularly review all new pronouncements to determine their impact, if any, on our financial statements.

Note 2 - Summary of Significa24

Note 2 - Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2016
Notes Tables
Revenue Recognition, Multiple-deliverable Arrangements [Table Text Block]	For the year ended Revenue activity December 31, 2016 December 31, 2015 Set-up fees $ 6,658,987 $ 6,649,762 Change orders 1,212,153 846,464 Maintenance 4,803,171 5,107,764 Software licenses 7,885,023 3,975,549 Professional services 3,843,641 3,145,883 Hosting 1,016,535 985,415 Total $ 25,419,510 $ 20,710,837
Allowance for Credit Losses on Financing Receivables [Table Text Block]	December 31, 2016 December 31, 2015 Beginning of period $ 116,834 $ 186,085 Bad debt expense 132,767 14,939 Write-offs (69,788 ) (84,190 ) End of period $ 179,813 $ 116,834
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	Revenues Accounts receivable For the year ended Number of customers Percentage of total revenues Number of customers Percentage of accounts receivable December 31, 2016 1 16% 2 21% December 31, 2015 1 16% 3 42%
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]	European revenues For the year ended December 31, 2016 December 31, 2015 European revenues % of Total revenues European revenues % of Total revenues $ 2,702,660 11% $ 2,150,096 10%

Note 3 - Earnings (Loss) Per 25

Note 3 - Earnings (Loss) Per Share (Tables)	12 Months Ended
	Dec. 31, 2016
Notes Tables
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Anti-dilutive security December 31, 2016 December 31, 2015 Preferred stock -0- 3,277,229 Employee stock options 275,000 125,000 Warrants 27,860,000 22,900,000 Convertible notes 15,490,000 -0- Shares issuable for accrued interest 150,016 1,054,081 Total 43,775,016 27,356,310
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	For the year ended December 31, 2016 December 31, 2015 Income/(loss) Shares Per-share Income/(loss) Shares Per-share numerator denominator amount numerator denominator amount Basic EPS $ 101,880 145,868,227 $ 0.00 $ 2,404,498 96,645,482 $ 0.02 Effect of dilutive securities -0- 294,200 0.00 43,316 16,900,259 0.00 Diluted EPS $ 101,880 146,162,427 $ 0.00 $ 2,447,814 113,545,741 $ 0.02

Note 4 - Property and Equipme26

Note 4 - Property and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2016
Notes Tables
Property, Plant and Equipment [Table Text Block]	December 31, 2016 December 31, 2015 Cost Accumulated depreciation Net book value Cost Accumulated depreciation Net book value Estimated useful life (years) Computer & office equipment $ 2,125,067 $ 1,761,879 $ 363,188 $ 2,055,956 $ 1,605,473 $ 450,483 5 Leasehold improvements 114,719 89,789 24,930 91,452 85,895 5,557 5 Computer software 1,925,462 1,720,399 205,063 1,843,483 1,621,492 221,991 3 Office furniture 158,436 114,065 44,371 111,660 105,979 5,681 5 Total $ 4,323,684 $ 3,686,132 $ 637,552 $ 4,102,551 $ 3,418,839 $ 683,712

Note 5 - Intangible Assets, N27

Note 5 - Intangible Assets, Net (Tables)	12 Months Ended
	Dec. 31, 2016
Notes Tables
Schedule of Finite-Lived Intangible Assets [Table Text Block]	December 31, 2016 December 31, 2015 Cost Accumulated amortization Net book value Cost Accumulated amortization Net book value Estimated useful life (years) eClinical Suite customer list $ 1,392,701 $ 1,392,701 $ -0- $ 1,392,701 $ 1,392,701 $ -0- 3 Promasys B.V. customer list 104,163 21,990 82,173 108,051 15,607 92,444 15 Promasys B.V. software code 72,837 46,130 26,707 72,837 31,563 41,274 5 Promasys B.V. URLs/website 52,608 52,608 -0- 54,572 39,413 15,159 3 Total $ 1,622,309 $ 1,513,429 $ 108,880 $ 1,628,161 $ 1,479,284 $ 148,877
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	2017 $ 21,512 2018 19,084 2019 6,944 2020 6,944 2021 6,944 Thereafter 47,452 Total $ 108,880

Note 6 - Accounts Payable and28

Note 6 - Accounts Payable and Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2016
Notes Tables
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	Account​ December 31, 2016 December 31, 2015 Accounts payable $ 697,060 $ 515,764 Accrued payroll and related costs 886,334 473,108 Other accrued expenses 431,961 105,562 Accrued interest 107,718 862,836 Total accounts payable and accrued expenses $ 2,123,073 $ 1,957,270

Note 7 - Line of Credit, Note29

Note 7 - Line of Credit, Notes Payable and Liquidity (Tables)	12 Months Ended
	Dec. 31, 2016
Notes Tables
Schedule of Debt [Table Text Block]	Ending principal Non related party Related party Origination Maturity Interest December 31, Long Long date date rate 2016 Current term Current term 2/29/2016 4/1/2019 12% $ 450,000 $ -0- $ -0- $ -0- $ 450,000 6/30/2016 4/1/2020 10% 420,000 -0- 420,000 -0- -0- 6/30/2016 4/1/2020 12% 372,500 -0- 372,500 -0- -0- Discount on notes payable -0- (455,285 ) -0- (237,664 ) Total $ 1,242,500 $ -0- $ 337,215 $ -0- $ 212,336 Ending principal Non related party Related party Origination Maturity Interest December 31, Long Long date date rate 2015 Current term Current term 4/4/2014 4/1/2017 12% $ 45,000 $ -0- $ 45,000 $ -0- $ -0- 4/4/2014 4/1/2017 12% 137,500 -0- 137,500 -0- -0- 4/4/2014 4/1/2017 10% 120,000 -0- 120,000 -0- -0- 12/1/2014 4/1/2017 10% 300,000 -0- 300,000 -0- -0- 12/1/2014 4/1/2017 12% 90,000 -0- 90,000 -0- -0- 12/1/2014 4/1/2017 12% 100,000 -0- 100,000 -0- -0- 4/1/2015 4/1/2018 12% 20,000 -0- -0- -0- 20,000 Discount on notes payable -0- -0- -0- -0- Total $ 812,500 $ -0- $ 792,500 $ -0- $ 20,000

Note 8 - Convertible Notes Pa30

Note 8 - Convertible Notes Payable (Tables)	12 Months Ended
	Dec. 31, 2016
Notes Tables
Schedule of Maturities of Long-term Debt [Table Text Block]	2017 $ 50,000 2018 450,000 2019 -0- 2020 6,550,000 Total $ 7,050,000
Convertible Debt [Member]
Notes Tables
Schedule of Long-term Debt Instruments [Table Text Block]	Principal at Carrying amount Date of Maturity Interest December 31, Short term Long term issuance date rate 2016 Related Non related Related Non related 3/26/1999 6/30/2004 10% $ 50,000 $ -0- $ 50,000 $ -0- $ -0- 8/29/2008 4/1/2018 10% 150,000 -0- -0- -0- 150,000 8/29/2008 4/1/2020 10% 1,770,000 -0- -0- 1,770,000 -0- 12/16/2008 4/1/2018 12% 200,000 -0- -0- -0- 200,000 12/16/2008 4/1/2020 12% 100,000 -0- -0- -0- 100,000 12/16/2008 4/1/2020 12% 4,055,000 -0- -0- 4,055,000 -0- 9/30/2009 4/1/2018 12% 100,000 -0- -0- -0- 100,000 9/30/2009 4/1/2020 12% 625,000 -0- -0- -0- 625,000 Total $ 7,050,000 $ -0- $ 50,000 $ 5,825,000 $ 1,175,000 Principal at Carrying amount Date of Maturity Interest December 31, Short term Long term issuance date rate 2015 Related Non related Related Non related 3/26/1999 6/30/2004 10% $ 75,000 $ -0- $ 75,000 $ -0- $ -0- 8/29/2008 4/1/2017 10% 150,000 -0- -0- -0- 150,000 8/29/2008 4/1/2017 10% 1,770,000 -0- -0- 1,770,000 -0- 12/16/2008 4/1/2017 12% 260,000 -0- -0- -0- 260,000 12/16/2008 4/1/2017 12% 4,055,000 -0- -0- 4,055,000 -0- 12/16/2008 4/1/2018 12% 215,000 -0- -0- -0- 215,000 12/16/2008 4/1/2018 12% 25,000 -0- -0- 25,000 -0- 9/30/2009 4/1/2017 12% 625,000 -0- -0- -0- 625,000 9/30/2009 4/1/2018 12% 100,000 -0- -0- -0- 100,000 Total $ 7,275,000 $ -0- $ 75,000 $ 5,850,000 $ 1,350,000

Note 9 - Fair Value Measureme31

Note 9 - Fair Value Measurement (Tables)	12 Months Ended
	Dec. 31, 2016
Notes Tables
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]	Fair value at Quoted prices in active markets for identical assets/ Significant other observable Significant unobservable December 31, 2016 liabilities (Level 1) inputs (Level 2) inputs (Level 3) Derivatives: (1) (2) Conversion feature liability $ 2,325,730 $ -0- $ -0- $ 2,325,730 Warrant liability 3,999,362 -0- -0- 3,999,362 Total of derivative liabilities $ 6,325,092 $ -0- $ -0- $ 6,325,092 Fair value at Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs December 31, 2015 (Level 1) (Level 2) (Level 3) Derivatives: (1) (2) Conversion feature liability $ 901,243 $ -0- $ -0- $ 901,243 Warrant liability 1,914,923 -0- -0- 1,914,923 Total of derivative liabilities $ 2,816,166 $ -0- $ -0- $ 2,816,166
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]	Significant valuation assumptions for derivative instruments at December 31, 2016 Risk free interest rate 0.82% to 1.45% Dividend yield 0.00% Expected volatility 117.3% to 143.8% Expected life (range in years) Conversion feature liability 1.25 to 3.25 Warrant liability 0.25 to 3.25 ​ Significant valuation assumptions for derivative instruments at December 31, 2015 Risk free interest rate 0.48% to 1.2% Dividend yield 0.00% Expected volatility 91.0% to 132.2% Expected life (range in years) Conversion feature liability 1.25 to 2.25 Warrant liability 0.00 to 3.01
Fair Value Measurements, Nonrecurring [Table Text Block]	Carrying amount Carrying amount Quoted prices in active markets for identical assets/ Significant other observable Significant unobservable December 31, 2015 December 31, 2016 liabilities (Level 1) inputs (Level 2) inputs (Level 3) Acquired assets (3) Promasys B.V. customer list (4) $ 92,444 $ 82,173 $ -0- $ -0- $ 136,253 Promasys B.V. software code (4) 41,274 26,707 -0- -0- 72,943 Promasys B.V. URLs/website (4) 15,159 -0- -0- -0- 68,814 Total $ 148,877 $ 108,880 $ -0- $ -0- $ 278,010 Carrying Amount Carrying Amount Quoted prices in active markets for identical assets/ Significant other observable Significant unobservable December 31, 2014 December 31, 2015 liabilities (Level 1) inputs (Level 2) inputs (Level 3) Acquired assets (3) Promasys B.V. customer list (4) $ 110,948 $ 92,444 $ -0- $ -0- $ 136,253 Promasys B.V. software code (4) 55,842 41,274 -0- -0- 72,943 Promasys B.V. URLs/website (4) 37,131 15,159 -0- -0- 68,814 Total $ 203,921 $ 148,877 $ -0- $ -0- $ 278,010
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Table Text Block]	Other income/(expense) For the year ended December 31, 2016 December 31, 2015 The net amount of gains/(losses) for the period included in earnings attributable to the unrealized and realized gains/(losses) from changes in derivative liabilities at the reporting date $ (2,657,910 ) $ 4,525,798 Total unrealized and realized gains/(losses) included in earnings $ (2,657,910 ) $ 4,525,798
Schedule of Derivative Liabilities at Fair Value [Table Text Block]	Level 3 financial liabilities at fair value Net purchases, Balance, issuances Balance, For the year ended beginning Net realized Net unrealized and Net transfers end December 31, 2016 of year gains/(losses) gains/(losses) settlements in and/or out of year Derivatives: Conversion feature liability $ (901,243 ) $ 29,108 $ (1,453,595 ) $ -0- $ -0- $ (2,325,730 ) Warrant liability (1,914,923 ) -0- (1,233,423 ) (851,016 ) -0- (3,999,362 ) Total of derivative liabilities $ (2,816,166 ) $ 29,108 $ (2,687,018 ) $ (851,016 ) $ -0- $ (6,325,092 ) Level 3 financial liabilities at fair value Net purchases, Balance, issuances Balance, For the year ended beginning Net realized Net unrealized and Net transfers end December 31, 2015 of year gains/(losses) gains/(losses) settlements in and/or out of year Derivatives: Conversion feature liability $ (2,944,402 ) $ 29,875 $ 2,013,284 $ -0- $ -0- $ (901,243 ) Warrant liability (6,695,060 ) -0- 2,482,639 (868,128 ) 3,165,626 (1,914,923 ) Total of derivative liabilities $ (9,639,462 ) $ 29,875 $ 4,495,923 $ (868,128 ) $ 3,165,626 $ (2,816,166 )

Note 10 - Commitments and Con32

Note 10 - Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2016
Notes Tables
Schedule Of Minimum Royalty Payments [Table Text Block]	2017 $ 655,832 2018 512,157 2019 421,230 2020 297,570 2021 269,962 Thereafter 310,550 Total $ 2,467,301
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	2017 $ 450,000 2018 164,500 Total $ 614,500

Note 12 - Stockholders' (Defi33

Note 12 - Stockholders' (Deficit) (Tables)	12 Months Ended
	Dec. 31, 2016
Notes Tables
Schedule Of Dividends In Arrears [Table Text Block]	Cumulative arrearage as of Cumulative arrearage per share as of December 31, December 31, Series of preferred stock 2016 2015 2016 2015 Series A $ -0- $ 2,465,830 $ -0- $ 0.68 Series B 609,887 609,887 $ 3.05 $ 3.05 Series C 1,472,093 1,472,093 $ 4.37 $ 4.37 Total preferred stock arrearage $ 2,081,980 $ 4,547,810
Schedule of Dividends Payable [Table Text Block]	Dividends accreted Dividends per share For the year ended For the year ended December 31, December 31, 2016 2015 2016 2015 Preferred stock dividends in arrears Series A $ -0- $ 181,886 $ -0- $ 0.050 Preferred stock dividends in arrears Series B $ -0- $ -0- $ -0- $ -0- Preferred stock dividends in arrears Series C $ -0- $ -0- $ -0- $ -0-
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	December 31, 2016 December 31, 2016 Warrants outstanding Warrants exercisable Weighted average Weighted average Weighted average Range of exercise price Number outstanding remaining contractual life exercise price Number exercisable exercise price $0.25 - $0.60 27,860,000 2.71 $ 0.42 27,860,000 $ 0.42 December 31, 2015 December 31, 2015 Warrants outstanding Warrants exercisable Weighted average Weighted average Weighted average Range of exercise price Number outstanding remaining contractual life exercise price Number exercisable exercise price $0.25 - $0.60 22,900,000 1.76 $ 0.46 22,900,000 $ 0.46
Schedule of Share-based Compensation, Activity [Table Text Block]	Weighted average grant date fair value for the year ended December 31, 2016 2015 Stock options granted during the period $ 0.19 $ 0.24 Stock options vested during the period $ 0.21 $ 0.17 Stock options forfeited during the period $ 0.28 $ 0.26
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	Foreign currency translation Accumulated other comprehensive (loss) Balance at December 31, 2014 $ (243,827 ) $ (243,827 ) 2015 Activity (122,528 ) (122,528 ) Balance at December 31, 2015 (366,355 ) (366,355 ) 2016 Activity (44,150 ) (44,150 ) Balance at December 31, 2016 $ (410,505 ) $ (410,505 )
Warrant [Member]
Notes Tables
Schedule of Share-based Compensation, Activity [Table Text Block]	Warrants Balance at December 31, 2014 48,463,517 Issued 3,800,000 Exercised -0- Cancelled (29,363,517 ) Expired/forfeited -0- Balance at December 31, 2015 22,900,000 Issued 4,970,000 Exercised -0- Expired/forfeited (10,000 ) Balance at December 31, 2016 27,860,000 Warrants exercisable at December 31, 2016 27,860,000 Weighted average fair value of warrants granted during 2016 $ 0.16

Note 13 - Employee Equity Inc34

Note 13 - Employee Equity Incentive Plans (Tables)	12 Months Ended
	Dec. 31, 2016
Notes Tables
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	Number of options Weighted average exercise price (per share) Weighted average remaining contractual term (in years) Aggregate intrinsic value Outstanding at December 31, 2014 3,130,000 $ 0.20 1.59 $ 364,900 Granted 225,000 0.25 Exercised (292,500 ) 0.12 Forfeited/cancelled/expired (1,060,000 ) 0.35 Outstanding at December 31, 2015 2,002,500 0.14 1.40 $ 198,990 Granted 450,000 0.20 Exercised (1,120,000 ) 0.12 Forfeited/cancelled/expired (107,500 ) 0.29 Outstanding at December 31, 2016 1,225,000 $ 0.17 2.62 $ 83,425 Vested and exercisable at December 31, 2016 737,500 $ 0.15 1.38 $ 64,550
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]	Fair value of options vesting for the year ended Number of options vested Fair value of options vested December 31, 2016 162,500 $ 33,622 December 31, 2015 200,000 $ 34,665
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	Awards breakdown by price range at December 31, 2016 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 850,000 2.15 $ 0.15 625,000 1.32 $ 0.14 0.21 to 0.29 375,000 3.70 0.23 112,500 1.67 0.21 0.30 to 0.49 -0- 0.00 0.00 -0- 0.00 0.00 0.50 to 0.70 -0- 0.00 0.00 -0- 0.00 0.00 0.00 to 0.70 1,225,000 2.62 $ 0.17 737,500 1.38 $ 0.15 Awards breakdown by price range at December 31, 2015 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 1,777,500 1.14 $ 0.13 1,652,500 0.93 $ 0.13 0.21 to 0.29 125,000 2.83 0.22 100,000 2.46 0.21 0.30 to 0.49 100,000 4.17 0.30 -0- 0.00 0.00 0.50 to 0.70 -0- 0.00 0.00 -0- 0.00 0.00 0.00 to 0.70 2,002,500 1.40 $ 0.14 1,752,500 1.02 $ 0.13
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Stock option assumptions for the year ended Stock option assumptions December 31, 2016 December 31, 2015 Risk-free interest rate 1.45% 1.20% Expected dividend yield 0.0% 0.0% Expected volatility 155.5% 183.8% Expected life of options (in years) 5 5
Schedule of Share-based Compensation, Activity [Table Text Block]	Weighted average grant date fair value for the year ended December 31, 2016 2015 Stock options granted during the period $ 0.19 $ 0.24 Stock options vested during the period $ 0.21 $ 0.17 Stock options forfeited during the period $ 0.28 $ 0.26
Schedule of Nonvested Share Activity [Table Text Block]	Shares underlying stock options Weighted average grant date fair value Nonvested shares at 250,000 $ 0.23 Nonvested shares at 487,500 $ 0.20

Note 14 - Income Taxes (Tables)

Note 14 - Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2016
Notes Tables
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	December 31, 2016 December 31, 2015 Federal statutory rate applied to income/(loss) before income taxes $ 38,740 $ 963,947 Increase/(decrease) in income taxes results from: Current tax expense/(benefit) 1,069 (24,739 ) Nondeductible expenses 1,078,519 (1,451,221 ) Change in deferred assets 41,019 97,580 Change in valuation allowance (1,158,278 ) 389,694 Income tax expense/(benefit) $ 1,069 $ (24,739 )
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	December 31, 2016 December 31, 2015 Current tax expense/(benefit): $ 1,069 $ (24,739 ) Deferred tax expense/(benefit): Bad debt allowance (23,699 ) 26,059 Operating loss carryforward 1,140,957 (513,333 ) Amortization of intangibles 5,482 5,482 Patent litigation settlement 35,538 92,098 1,159,347 (414,433 ) Valuation allowance (1,158,278 ) 389,694 Total tax expense/(benefit) $ 1,069 $ (24,739 )
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	December 31, 2016 December 31, 2015 Amortization of intangibles $ 267,253 $ 272,734 Bad debt allowance 66,662 42,963 Patent litigation liability accrual 128,804 164,342 Operating loss carryforwards 19,034,573 20,175,531 Gross deferred tax assets 19,497,292 20,655,570 Valuation allowance (19,497,292 ) (20,655,570 ) Net deferred tax liability/(asset) $ -0- $ -0-

Note 1 - Organization and Nat36

Note 1 - Organization and Nature of Operations (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Research and Development Expense	$ 2,598,962	$ 2,639,577

Note 2 - Summary of Significa37

Note 2 - Summary of Significant Accounting Policies (Details Textual)	12 Months Ended
	Dec. 31, 2016USD ($)shares	Dec. 31, 2015USD ($)	Jul. 10, 2009shares
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	$ (44,150)	$ (122,528)
Number of Reportable Segments	1
Number of Revenue Producing Activities	4
Allowance for Doubtful Accounts Receivable, Current	$ 179,813	116,834
Cash, Uninsured Amount	1,237,118
Revenues	$ 25,419,510	20,710,837
Property, Plant and Equipment, Useful Life
Deferred Revenue	$ 9,539,230
Deferred Revenue, Current	7,250,061	7,054,614
Advertising Expense	712,179	635,267
Research and Development Expense	$ 2,598,962	$ 2,639,577
The 2016 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares	10,000,000
Common Stock Available for Issuance Increasing Period	9 years
Common Stock Available for Issuance, Annual Increase Percent	5.00%
Plan 2009 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares			7,500,000
Leasehold Improvements Computers Equipment And Furniture [Member]
Property, Plant and Equipment, Useful Life	5 years
Software Development [Member]
Property, Plant and Equipment, Useful Life	3 years
Sales Revenue, Net [Member] | Customer Concentration Risk [Member]
Concentration Risk, Percentage	16.00%	16.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member]
Concentration Risk, Percentage	21.00%	42.00%
Customer 1 [Member] | Sales Revenue, Net [Member] | Customer Concentration Risk [Member]
Concentration Risk, Percentage	16.00%	16.00%
Revenues	$ 4,167,000	$ 3,237,000
Customer 1 [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]
Concentration Risk, Percentage	11.00%	16.00%
Customer 2 [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]
Concentration Risk, Percentage	11.00%
Minimum [Member]
Term Of Software License	3 years
Deferred Revenue, Service Contract Term	30 days
Maximum [Member]
Term Of Software License	5 years
Deferred Revenue, Service Contract Term	5 years

Note 2 - Summary of Significa38

Note 2 - Summary of Significant Accounting Policies - Revenue by Business Activity (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Revenues	$ 25,419,510	$ 20,710,837
Set Up Fees [Member]
Revenues	6,658,987	6,649,762
Change Orders [Member]
Revenues	1,212,153	846,464
Maintenance [Member]
Revenues	4,803,171	5,107,764
Software Licenses [Member]
Revenues	7,885,023	3,975,549
Professional Services [Member]
Revenues	3,843,641	3,145,883
Hosting [Member]
Revenues	$ 1,016,535	$ 985,415

Note 2 - Summary of Significa39

Note 2 - Summary of Significant Accounting Policies - Allowance for Doubtful Account Summary (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Beginning of period	$ 116,834	$ 186,085
Bad debt expense	132,767	14,939
Write-offs	(69,788)	(84,190)
End of period	$ 179,813	$ 116,834

Note 2 - Summary of Significa40

Note 2 - Summary of Significant Accounting Policies - Customer Concentration (Details) - Customer Concentration Risk [Member]	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Sales Revenue, Net [Member]
Number of customers	1	1
Concentration risk, percentage	16.00%	16.00%
Accounts Receivable [Member]
Number of customers	2	3
Concentration risk, percentage	21.00%	42.00%

Note 2 - Summary of Significa41

Note 2 - Summary of Significant Accounting Policies - Revenue From European Operations (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
European revenues	$ 25,419,510	$ 20,710,837
Reportable Geographical Components [Member] | Europe [Member]
European revenues	$ 2,702,660	$ 2,150,096
Concentration risk, percentage	11.00%	10.00%

Note 3 - Earnings (Loss) Per 42

Note 3 - Earnings (Loss) Per Share (Details Textual) - $ / shares	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Weighted Average Number of Shares Outstanding, Basic	145,868,227	96,645,482
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	43,775,016	27,356,310
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 0.15
Lower Range Limit [Member]
Debt Instrument, Convertible, Conversion Price	0.25
Upper Range Limit [Member]
Debt Instrument, Convertible, Conversion Price	0.50
Lower Range Limit [Member]
Investment Warrants, Exercise Price	0.25
Upper Range Limit [Member]
Investment Warrants, Exercise Price	0.60
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	0.045
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 0.24

Note 3 - Earnings (Loss) Per 43

Note 3 - Earnings (Loss) Per Share - Reconciliation of Anti-dilutive Securities (Details) - shares	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Anti-dilutive Security (in shares)	43,775,016	27,356,310
Shares Of Preferred Stock [Member]
Anti-dilutive Security (in shares)	0	3,277,229
Employee Stock Option [Member]
Anti-dilutive Security (in shares)	275,000	125,000
Warrant [Member]
Anti-dilutive Security (in shares)	27,860,000	22,900,000
Convertible Debt Securities [Member]
Anti-dilutive Security (in shares)	15,490,000	0
Shares Issuable For Accrued Interest [Member]
Anti-dilutive Security (in shares)	150,016	1,054,081

Note 3 - Earnings (Loss) Per 44

Note 3 - Earnings (Loss) Per Share - Computation of Diluted Earnings Per Share (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Basic EPS, Income (loss) numerator	$ 101,880	$ 2,404,498
Weighted Average Number of Shares Outstanding, Basic	145,868,227	96,645,482
Basic EPS, Per-share amount (in dollars per share)	$ 0	$ 0.02
Effect of dilutive securities, Income (loss) numerator	$ 0	$ 43,316
Effect of dilutive securities, Shares denominator (in shares)	294,200	16,900,259
Effect of dilutive securities, Per-share amount (in dollars per share)	$ 0	$ 0
Diluted EPS, Income (loss) numerator	$ 101,880	$ 2,447,814
Diluted EPS, Shares denominator (in shares)	146,162,427	113,545,741
Diluted EPS (in dollars per share)	$ 0	$ 0.02

Note 4 - Property and Equipme45

Note 4 - Property and Equipment, Net (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Depreciation	$ 302,893	$ 233,798

Note 4 - Property and Equipme46

Note 4 - Property and Equipment, Net - Property and Equipment (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Cost	$ 4,323,684	$ 4,102,551
Accumulated Depreciation	3,686,132	3,418,839
Net Book Value	$ 637,552	683,712
Estimated Useful Lives (Year)
Computer And Office Equipment [Member]
Cost	$ 2,125,067	2,055,956
Accumulated Depreciation	1,761,879	1,605,473
Net Book Value	$ 363,188	450,483
Estimated Useful Lives (Year)	5 years
Leasehold Improvements [Member]
Cost	$ 114,719	91,452
Accumulated Depreciation	89,789	85,895
Net Book Value	$ 24,930	5,557
Estimated Useful Lives (Year)	5 years
Computer Equipment [Member]
Cost	$ 1,925,462	1,843,483
Accumulated Depreciation	1,720,399	1,621,492
Net Book Value	$ 205,063	221,991
Estimated Useful Lives (Year)	3 years
Furniture and Fixtures [Member]
Cost	$ 158,436	111,660
Accumulated Depreciation	114,065	105,979
Net Book Value	$ 44,371	$ 5,681
Estimated Useful Lives (Year)	5 years

Note 5 - Intangible Assets, N47

Note 5 - Intangible Assets, Net (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Amortization of Intangible Assets	$ 37,331	$ 40,338

Note 5 - Intangible Assets, N48

Note 5 - Intangible Assets, Net - Intangible Assets (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Cost	$ 1,622,309	$ 1,628,161
Accumulated amortization	1,513,429	1,479,284
Net Book Value	108,880	148,877
eClinical Customer List [Member]
Cost	1,392,701	1,392,701
Accumulated amortization	1,392,701	1,392,701
Net Book Value	$ 0	0
Finite-Lived Intangible Asset, Useful Life	3 years
Promasys B.V. Customer List [Member]
Cost	$ 104,163	108,051
Accumulated amortization	21,990	15,607
Net Book Value	$ 82,173	92,444
Finite-Lived Intangible Asset, Useful Life	15 years
Promasys B.V. Software Code [Member]
Cost	$ 72,837	72,837
Accumulated amortization	46,130	31,563
Net Book Value	$ 26,707	41,274
Finite-Lived Intangible Asset, Useful Life	5 years
Promasys B.V. URLs/Website [Member]
Cost	$ 52,608	54,572
Accumulated amortization	52,608	39,413
Net Book Value	$ 0	$ 15,159
Finite-Lived Intangible Asset, Useful Life	3 years

Note 5 - Intangible Assets, N49

Note 5 - Intangible Assets, Net - Intangible Assets, Future Amortization Expense (Details)	Dec. 31, 2016USD ($)
2,017	$ 21,512
2,018	19,084
2,019	6,944
2,020	6,944
2,021	6,944
Thereafter	47,452
Total	$ 108,880

Note 6 - Accounts Payable and50

Note 6 - Accounts Payable and Accrued Expenses - Accounts Payable and Accrued Expenses (Details) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Accounts payable	$ 697,060	$ 515,764
Accrued payroll and related costs	886,334	473,108
Other accrued expenses	431,961	105,562
Accrued interest	107,718	862,836
Total accounts payable and accrued expenses	$ 2,123,073	$ 1,957,270

Note 7 - Line of Credit, Note51

Note 7 - Line of Credit, Notes Payable and Liquidity (Details Textual) - USD ($)	Dec. 14, 2016	Dec. 05, 2016	Jun. 30, 2016	Feb. 29, 2016	Dec. 17, 2015	Nov. 23, 2015	Nov. 19, 2015	Oct. 15, 2015	Jan. 31, 2015	Mar. 18, 2013	Dec. 31, 2016	Dec. 31, 2015	Apr. 01, 2015	Feb. 03, 2015	Dec. 18, 2013
Line of Credit Facility, Maximum Borrowing Capacity										$ 2,000,000				$ 5,000,000	$ 4,000,000
Debt Instrument, Interest Rate, Stated Percentage										2.00%
Debt Instrument, Periodic Payment, Interest										$ 9,500
Long-term Line of Credit											$ 2,700,000
Line of Credit Facility, Interest Rate at Period End											2.75%
Unsecured Debt											$ 1,242,500	$ 812,500
Debt Instrument, Face Amount											$ 7,050,000	$ 7,275,000
Class of Warrant or Right, Exercise Price of Warrants or Rights
Debt Conversion, Converted Instrument, Amount											$ 0	$ 1,915,000
Class of Warrant or Right Cancelled During the Period												29,363,517
Chief Executive Officer and Director Mr. Wit [Member]
Repayments of Long-term Debt									$ 6,879
Class of Warrant or Right Cancelled During the Period							11,440,000
Chief Executive Officer and Director Mr. Wit [Member] | Related Warrants [Member]
Warrants Sold During the Period					2,000,000	4,000,000
Class of Warrant or Right Cancelled During the Period							400,000
Chief Executive Officer and Director Mr. Wit [Member] | Unrelated Warrants [Member]
Class of Warrant or Right Cancelled During the Period							6,000,000
Chief Executive Officer and Director Mr. Wit [Member] | Matures On January 1, 2019 III [Member]
Debt Conversion, Converted Instrument, Amount								$ 529,000
Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares							2,116,000
Chief Executive Officer and Director Mr. Wit [Member] | Matures on January 1, 2019 [Member]
Debt Conversion, Converted Instrument, Rate								12.00%
Chief Executive Officer and Director Mr. Wit [Member] | Matures On January 1, 2019 IV [Member]
Debt Conversion, Converted Instrument, Amount								$ 2,860,000
Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares							11,440,000
Chief Executive Officer and Director Mr. Wit [Member] | Matures On January 1, 2019 V [Member]
Debt Conversion, Converted Instrument, Amount								$ 950,000
Debt Conversion, Converted Instrument, Rate								12.00%
Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares							3,800,000
Matures on April 1, 2019 [Member] | Chief Executive Officer and Director Mr. Wit [Member]
Debt Instrument, Interest Rate, Stated Percentage				12.00%
Debt Instrument, Face Amount				$ 450,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				1,800,000
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 0.25
Extinguishment of Debt, Amount				$ 450,000
Warrants Sold During the Period		1,000,000
Warrants and Rights Outstanding				325,689
Debt Instrument, Fair Value Disclosure				$ 124,311
Amortization Period of Warrant Liabilities				3 years 30 days
Matures April 1, 2020 I [Member] | Investor [Member]
Debt Instrument, Interest Rate, Stated Percentage			12.00%
Debt Instrument, Face Amount			$ 372,500
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			1,490,000
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 0.25
Warrants and Rights Outstanding			$ 246,921
Debt Instrument, Fair Value Disclosure			$ 125,579
Amortization Period of Warrant Liabilities			3 years 270 days
Repayments of Debt	$ 90,000
Matures April 1, 2020 II [Member] | Investor [Member]
Debt Instrument, Interest Rate, Stated Percentage			10.00%
Debt Instrument, Face Amount			$ 420,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			1,680,000
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 0.25
Warrants and Rights Outstanding			$ 278,408
Debt Instrument, Fair Value Disclosure			$ 141,592
Amortization Period of Warrant Liabilities			3 years 270 days
Note Payable 14 [Member] | Chief Executive Officer and Director Mr. Wit [Member]
Debt Instrument, Interest Rate, Stated Percentage									12.00%
Debt Instrument, Face Amount									$ 529,000
Debt Conversion, Converted Instrument, Rate									12.00%
Note Payable 15 [Member] | Chief Executive Officer and Director Mr. Wit [Member]
Debt Instrument, Face Amount									$ 2,860,000
Note Payable 16 [Member] | Chief Executive Officer and Director Mr. Wit [Member]
Debt Instrument, Interest Rate, Stated Percentage									12.00%
Debt Instrument, Face Amount									$ 950,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights									3,800,000
Class of Warrant or Right, Exercise Price of Warrants or Rights									$ 0.25
Debt Instrument, Repurchase Amount									$ 280,000
Interest Payable									$ 670,000
Note Payable 17 [Member] | Chairman and Chief Technology Officer [Member]
Debt Instrument, Interest Rate, Stated Percentage													12.00%
Debt Instrument, Face Amount													$ 20,000
Matures on January 1, 2019 [Member] | Chief Executive Officer and Director Mr. Wit [Member]
Debt Conversion, Converted Instrument, Amount								$ 980,000
Debt Conversion, Converted Instrument, Rate								12.00%
Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares							3,920,000
Matures On January 1, 2019 II [Member] | Chief Executive Officer and Director Mr. Wit [Member]
Debt Conversion, Converted Instrument, Amount								$ 1,600,000
Debt Conversion, Converted Instrument, Rate								12.00%
Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares							6,400,000

Note 7 - Line of Credit, Note52

Note 7 - Line of Credit, Notes Payable and Liquidity - Notes Payable (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Mar. 18, 2013
Debt Instrument, Interest Rate, Stated Percentage			2.00%
Ending principal	$ 1,242,500	$ 812,500
Discount on notes payable
Short-term Debt [Member] | Non-Related Party [Member]
Ending principal	0	0
Discount on notes payable	0	0
Short-term Debt [Member] | Related Party [Member]
Ending principal	0	0
Discount on notes payable	0	0
Long-term Debt [Member] | Non-Related Party [Member]
Ending principal	337,215	792,500
Discount on notes payable	(455,285)	0
Long-term Debt [Member] | Related Party [Member]
Ending principal	212,336	20,000
Discount on notes payable	$ (237,664)	$ 0
Notes Payable, Matures April 1, 2019 [Member]
Maturity date	Apr. 1, 2019
Debt Instrument, Interest Rate, Stated Percentage	12.00%
Ending principal	$ 450,000
Notes Payable, Matures April 1, 2019 [Member] | Short-term Debt [Member] | Non-Related Party Current [Member]
Ending principal	0
Notes Payable, Matures April 1, 2019 [Member] | Short-term Debt [Member] | Related Party [Member]
Ending principal	0
Notes Payable, Matures April 1, 2019 [Member] | Long-term Debt [Member] | Non-Related Party Current [Member]
Ending principal	0
Notes Payable, Matures April 1, 2019 [Member] | Long-term Debt [Member] | Related Party [Member]
Ending principal	$ 450,000
Notes Payable, Matures April 1, 2017 [Member]
Maturity date		Apr. 1, 2017
Debt Instrument, Interest Rate, Stated Percentage		12.00%
Ending principal		$ 45,000
Notes Payable, Matures April 1, 2017 [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Ending principal		0
Notes Payable, Matures April 1, 2017 [Member] | Short-term Debt [Member] | Related Party [Member]
Ending principal		0
Notes Payable, Matures April 1, 2017 [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Ending principal		45,000
Notes Payable, Matures April 1, 2017 [Member] | Long-term Debt [Member] | Related Party [Member]
Ending principal		$ 0
Notes Payable, Matures April 1, 2020 I [Member]
Maturity date	Apr. 1, 2020
Debt Instrument, Interest Rate, Stated Percentage	10.00%
Ending principal	$ 420,000
Notes Payable, Matures April 1, 2020 I [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Ending principal	0
Notes Payable, Matures April 1, 2020 I [Member] | Short-term Debt [Member] | Related Party [Member]
Ending principal	0
Notes Payable, Matures April 1, 2020 I [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Ending principal	420,000
Notes Payable, Matures April 1, 2020 I [Member] | Long-term Debt [Member] | Related Party [Member]
Ending principal	$ 0
Notes Payable, Matures April 1, 2017 II [Member]
Maturity date		Apr. 1, 2017
Debt Instrument, Interest Rate, Stated Percentage		12.00%
Ending principal		$ 137,500
Notes Payable, Matures April 1, 2017 II [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Ending principal		0
Notes Payable, Matures April 1, 2017 II [Member] | Short-term Debt [Member] | Related Party [Member]
Ending principal		0
Notes Payable, Matures April 1, 2017 II [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Ending principal		137,500
Notes Payable, Matures April 1, 2017 II [Member] | Long-term Debt [Member] | Related Party [Member]
Ending principal		$ 0
Notes Payable, Matures April 1, 2020 II [Member]
Maturity date	Apr. 1, 2020
Debt Instrument, Interest Rate, Stated Percentage	12.00%
Ending principal	$ 372,500
Notes Payable, Matures April 1, 2020 II [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Ending principal	0
Notes Payable, Matures April 1, 2020 II [Member] | Short-term Debt [Member] | Related Party [Member]
Ending principal	0
Notes Payable, Matures April 1, 2020 II [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Ending principal	372,500
Notes Payable, Matures April 1, 2020 II [Member] | Long-term Debt [Member] | Related Party [Member]
Ending principal	$ 0
Notes Payable, Matures April 1, 2017 III [Member]
Maturity date		Apr. 1, 2017
Debt Instrument, Interest Rate, Stated Percentage		10.00%
Ending principal		$ 120,000
Notes Payable, Matures April 1, 2017 III [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Ending principal		0
Notes Payable, Matures April 1, 2017 III [Member] | Short-term Debt [Member] | Related Party [Member]
Ending principal		0
Notes Payable, Matures April 1, 2017 III [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Ending principal		120,000
Notes Payable, Matures April 1, 2017 III [Member] | Long-term Debt [Member] | Related Party [Member]
Ending principal		$ 0
Notes Payable, Matures April 1, 2017 IV [Member]
Maturity date		Apr. 1, 2017
Debt Instrument, Interest Rate, Stated Percentage		10.00%
Ending principal		$ 300,000
Notes Payable, Matures April 1, 2017 IV [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Ending principal		0
Notes Payable, Matures April 1, 2017 IV [Member] | Short-term Debt [Member] | Related Party [Member]
Ending principal		0
Notes Payable, Matures April 1, 2017 IV [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Ending principal		300,000
Notes Payable, Matures April 1, 2017 IV [Member] | Long-term Debt [Member] | Related Party [Member]
Ending principal		$ 0
Notes Payable, Matures April 1, 2017 V [Member]
Maturity date		Apr. 1, 2017
Debt Instrument, Interest Rate, Stated Percentage		12.00%
Ending principal		$ 90,000
Notes Payable, Matures April 1, 2017 V [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Ending principal		0
Notes Payable, Matures April 1, 2017 V [Member] | Short-term Debt [Member] | Related Party [Member]
Ending principal		0
Notes Payable, Matures April 1, 2017 V [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Ending principal		90,000
Notes Payable, Matures April 1, 2017 V [Member] | Long-term Debt [Member] | Related Party [Member]
Ending principal		$ 0
Notes Payable, Matures April 1, 2017 VI [Member]
Maturity date		Apr. 1, 2017
Debt Instrument, Interest Rate, Stated Percentage		12.00%
Ending principal		$ 100,000
Notes Payable, Matures April 1, 2017 VI [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Ending principal		0
Notes Payable, Matures April 1, 2017 VI [Member] | Short-term Debt [Member] | Related Party [Member]
Ending principal		0
Notes Payable, Matures April 1, 2017 VI [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Ending principal		100,000
Notes Payable, Matures April 1, 2017 VI [Member] | Long-term Debt [Member] | Related Party [Member]
Ending principal		$ 0
Notes Payable, Matures April 1, 2018 [Member]
Maturity date		Apr. 1, 2018
Debt Instrument, Interest Rate, Stated Percentage		12.00%
Ending principal		$ 20,000
Notes Payable, Matures April 1, 2018 [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Ending principal		0
Notes Payable, Matures April 1, 2018 [Member] | Short-term Debt [Member] | Related Party [Member]
Ending principal		0
Notes Payable, Matures April 1, 2018 [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Ending principal		0
Notes Payable, Matures April 1, 2018 [Member] | Long-term Debt [Member] | Related Party [Member]
Ending principal		$ 20,000

Note 8 - Convertible Notes Pa53

Note 8 - Convertible Notes Payable (Details Textual) - USD ($)

Nov. 23, 2015

Nov. 19, 2015

May 01, 2015

Mar. 30, 2011

Sep. 30, 2009

Dec. 31, 1999

Aug. 29, 2008

Dec. 31, 2016

Dec. 31, 2015

Jun. 30, 2016

Feb. 29, 2016

Jun. 30, 2015

May 07, 2015

Apr. 30, 2015

Apr. 27, 2015

Apr. 02, 2015

Apr. 01, 2015

Jan. 31, 2015

Jul. 31, 2014

Apr. 28, 2014

Apr. 21, 2014

Dec. 31, 2013

Mar. 18, 2013

Mar. 12, 2013

Mar. 06, 2013

Feb. 27, 2013

Feb. 22, 2013

Sep. 30, 2011

Dec. 31, 2009

Dec. 16, 2008

Jun. 30, 2008

Jun. 30, 2004

Convertible Notes Payable

$ 0

$ 0

Debt Instrument, Interest Rate, Stated Percentage

2.00%

Debt Conversion, Converted Instrument, Amount

$ 0

$ 1,915,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

Repayments of Notes Payable

$ 245,000

$ 75,000

Class of Warrant or Right Cancelled During the Period

29,363,517

Chief Executive Officer and Director Mr. Wit [Member]

Class of Warrant or Right Cancelled During the Period

11,440,000

Director Mr. Wit [Member]

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.25

Class of Warrant or Right Cancelled During the Period

1,900,000

Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares

37,023,517

Chief Executive Officer [Member]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Interest Payable

$ 450,000

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

1,800,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.25

Convertible Notes 10% [Member]

Convertible Notes Payable

$ 862,500

Payments of Debt Issuance Costs

119,625

Proceeds from Issuance of Debt

$ 742,875

Debt Instrument, Interest Rate, Stated Percentage

10.00%

Debt Instrument, Convertible, Conversion Price

$ 1.25

Debt Conversion, Converted Instrument, Amount

$ 812,500

Debt Conversion, Converted Instrument, Shares Issued

1,495,179

Long-term Debt, Gross

$ 50,000

Interest Payable

$ 88,210

Secured Convertible Debenture [Member]

Convertible Notes Payable

$ 1,400,000

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Proceeds from Issuance of Secured Debt

$ 1,400,000

Repayments of Notes Payable

$ 200,000

Secured Convertible Debenture [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable

1,200,000

Secured Convertible Debenture [Member] | Chief Executive Officer and Director Mr. Wit [Member]

Convertible Notes Payable

$ 1,100,000

$ 1,100,000

Debt Instrument, Convertible, Conversion Price

$ 0.25

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

5,600,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.25

Secured Convertible Debenture [Member] | Chief Executive Officer and Director Mr. Wit [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable

$ 1,100,000

Secured Convertible Debenture [Member] | Lenders [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable

$ 625,000

$ 100,000

1,200,000

Secured Convertible Debenture [Member] | Director Mr. Wit [Member]

Debt Conversion, Converted Instrument, Amount

$ 475,000

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

1,900,000

Extinguishment of Debt, Amount

$ 475,000

Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares

1,900,000

Increase (Decrease) in Notes Payable, Related Parties

$ 625,000

Convertible Debentures Issued August 2008 [Member]

Convertible Notes Payable

$ 2,270,000

Convertible Debentures Issued August 2008 [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable

1,770,000

1,770,000

Convertible Debentures Issued August 2008 [Member] | Chief Officer, Mr. Wit and Mr. Van Kesteren [Member]

Debt Instrument, Interest Rate, Stated Percentage

10.00%

Debt Instrument, Convertible, Conversion Price

$ 0.50

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

4,540,000

Convertible Debentures Issued August 2008 [Member] | Mr. van Kesteren and Mr. Wit [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable

$ 1,920,000

150,000

Convertible Debentures Issued August 2008 [Member] | Director Mr. van Kesteren [Member] | Non-Related Party [Member]

Convertible Notes Payable

$ 150,000

Convertible Debentures Issued August 2008 [Member] | Director Mr. van Kesteren [Member] | Extended Maturity Debentures 2 [Member]

Convertible Notes Payable

$ 150,000

Convertible Debentures [Member] | Lenders [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable

$ 1,440,000

Convertible Debentures [Member] | Director Mr. Wit [Member]

Convertible Notes Payable

$ 510,000

Debt Conversion, Converted Instrument, Amount

$ 510,000

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

5,760,000

Convertible Debentures [Member] | Chief Officer, Mr. Wit and Mr. Van Kesteren [Member]

Convertible Notes Payable

$ 150,000

Convertible Debentures [Member] | Chief Operating Officer [Member]

Convertible Notes Payable

$ 25,000

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Matures April 1, 2020 I [Member] | Director Mr. Wit [Member]

Convertible Notes Payable

4,055,000

Matures April 1, 2020 I [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures 2 [Member]

Convertible Notes Payable

1,770,000

Notes Payable, Matures April 1, 2018 [Member]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Notes Payable, Matures April 1, 2018 [Member] | Chief Officer, Mr. Wit and Mr. Van Kesteren [Member]

Convertible Notes Payable

160,000

Notes Payable, Matures April 1, 2018 [Member] | Chief Officer, Mr. Wit and Mr. Van Kesteren [Member] | Extended Maturity Debentures 2 [Member]

Convertible Notes Payable

150,000

Convertible Debentures Issued December 2008 [Member]

Convertible Notes Payable

$ 5,075,000

Convertible Debentures Issued December 2008 [Member] | Non-Related Party [Member]

Convertible Notes Payable

$ 160,000

Convertible Debentures Issued December 2008 [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable

$ 360,000

Convertible Debentures Issued December 2008 [Member] | Lenders [Member]

Convertible Notes Payable

$ 100,000

$ 200,000

Debt Instrument, Interest Rate, Stated Percentage

12.00%

12.00%

Convertible Debentures Issued December 2008 [Member] | Lenders [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable

$ 100,000

$ 100,000

$ 200,000

4,505,000

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Convertible Debentures Issued December 2008 [Member] | Director Mr. Wit [Member]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

1,680,000

Class of Warrant or Right Cancelled During the Period

1,680,000

Extinguishment of Debt, Amount

$ 420,000

Convertible Debentures Issued December 2008 [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable

$ 4,475,000

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Convertible Debentures Issued December 2008 [Member] | Director Mr. van Kesteren [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable

$ 160,000

$ 160,000

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Convertible Debentures Issued December 2008 [Member] | Chief Executive Officer, Director, Chief Operating Officer, Chairman, Chief Technology Officer, Chief Financial Officer and Directors [Member]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Debt Instrument, Convertible, Conversion Price

$ 0.50

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

10,150,000

Convertible Debentures Issued December 2008 [Member] | Officers, Directors and Affiliate [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable

$ 4,980,000

Convertible Debentures Issued December 2008 [Member] | Chief Executive Officer [Member]

Convertible Notes Payable

4,475,000

Convertible Debentures Issued December 2008 [Member] | Chief Operating Officer [Member]

Convertible Notes Payable

25,000

Convertible Debentures Issued December 2008 [Member] | Chairman and Chief Technology Officer [Member]

Convertible Notes Payable

$ 5,000

5,000

Related Party Transaction, Amounts of Transaction

$ 5,000

Convertible Debentures Issued December 2008 [Member] | Former Director [Member]

Convertible Notes Payable

$ 15,000

Convertible Debentures Issued December 2008 [Member] | Former Director [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable

$ 15,000

Convertible Debentures Issued December 2008 [Member] | President [Member]

Convertible Notes Payable

$ 25,000

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Matures April 1, 2020 II [Member] | Lenders [Member]

Convertible Notes Payable

$ 100,000

Convertible Debentures Issued December 2009 [Member]

Convertible Notes Payable

$ 1,490,000

Debt Instrument, Convertible, Conversion Price

$ 0.25

Extinguishment of Debt, Amount

1,440,000

Convertible Debentures Issued December 2009 [Member] | Chief Executive Officer and Director Mr. Wit [Member]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

5,960,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.25

Convertible Debentures Issued December 2009 [Member] | Lenders [Member] | Extended Maturity Debentures [Member]

Convertible Notes Payable

$ 50,000

$ 1,490,000

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Convertible Debentures Issued December 2009 [Member] | Lenders [Member] | Extended Maturity Debentures 2 [Member]

Convertible Notes Payable

$ 1,490,000

Convertible Debentures Issued December 2009 [Member] | Director Mr. Wit [Member]

Debt Conversion, Converted Instrument, Amount

$ 1,440,000

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

5,760,000

Class of Warrant or Right Cancelled During the Period

5,760,000

Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares

5,760,000

Convertible Debentures Issued December 2009 [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures 2 [Member]

Convertible Notes Payable

$ 1,440,000

Note 8 - Convertible Notes Pa54

Note 8 - Convertible Notes Payable - Convertible Debt (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Mar. 18, 2013
Debt Instrument, Interest Rate, Stated Percentage			2.00%
Debt Instrument, Face Amount	$ 7,050,000	$ 7,275,000
Convertible Notes Payable	0	0
Convertible notes payable, current portion	50,000	75,000
Convertible notes payable, related parties, long term, net of current portion	5,825,000	5,850,000
Non-Related Party [Member]
Convertible notes payable, current portion	50,000	75,000
Convertible notes payable, related parties, long term, net of current portion	1,175,000	1,350,000
Related Party [Member]
Convertible notes payable, current portion	$ 5,825,000	$ 5,850,000
Convertible Note Payable 10% $862,500 [Member]
Maturity date	Jun. 30, 2004	Jun. 30, 2004
Debt Instrument, Interest Rate, Stated Percentage	10.00%	10.00%
Debt Instrument, Face Amount	$ 50,000	$ 75,000
Convertible Notes Payable	0	0
Convertible Note Payable 10% $862,500 [Member] | Non-Related Party [Member]
Convertible notes payable, current portion	50,000	75,000
Convertible notes payable, related parties, long term, net of current portion	0	0
Convertible Note Payable 10% $862,500 [Member] | Related Party [Member]
Convertible notes payable, current portion	$ 0	$ 0
Convertible Notes Payable 10% $150,000 [Member]
Maturity date	Apr. 1, 2018	Apr. 1, 2017
Debt Instrument, Interest Rate, Stated Percentage	10.00%	10.00%
Debt Instrument, Face Amount	$ 150,000	$ 150,000
Convertible Notes Payable	0	0
Convertible Notes Payable 10% $150,000 [Member] | Non-Related Party [Member]
Convertible notes payable, current portion	0	0
Convertible notes payable, related parties, long term, net of current portion	150,000	150,000
Convertible Notes Payable 10% $150,000 [Member] | Related Party [Member]
Convertible notes payable, current portion	$ 0	$ 0
Convertible Notes Payable 10% $2,120,000 [Member]
Maturity date	Apr. 1, 2020	Apr. 1, 2017
Debt Instrument, Interest Rate, Stated Percentage	10.00%	10.00%
Debt Instrument, Face Amount	$ 1,770,000	$ 1,770,000
Convertible Notes Payable	0	0
Convertible Notes Payable 10% $2,120,000 [Member] | Non-Related Party [Member]
Convertible notes payable, current portion	0	0
Convertible notes payable, related parties, long term, net of current portion	0	0
Convertible Notes Payable 10% $2,120,000 [Member] | Related Party [Member]
Convertible notes payable, current portion	$ 1,770,000	$ 1,770,000
Convertible Notes Payable 12 Percent 375,000 [Member]
Maturity date	Apr. 1, 2018
Debt Instrument, Interest Rate, Stated Percentage	12.00%
Debt Instrument, Face Amount	$ 200,000
Convertible Notes Payable	0
Convertible Notes Payable 12 Percent 375,000 [Member] | Non-Related Party [Member]
Convertible notes payable, current portion	0
Convertible notes payable, related parties, long term, net of current portion	200,000
Convertible Notes Payable 12 Percent 375,000 [Member] | Related Party [Member]
Convertible notes payable, current portion	$ 0
Convertible Notes Payable 12 Percent 260,000 [Member]
Maturity date		Apr. 1, 2017
Debt Instrument, Interest Rate, Stated Percentage		12.00%
Debt Instrument, Face Amount		$ 260,000
Convertible Notes Payable		0
Convertible Notes Payable 12 Percent 260,000 [Member] | Non-Related Party [Member]
Convertible notes payable, current portion		0
Convertible notes payable, related parties, long term, net of current portion		260,000
Convertible Notes Payable 12 Percent 260,000 [Member] | Related Party [Member]
Convertible notes payable, current portion		$ 0
Convertible Notes Payable12 Percent,100,000 [Member]
Maturity date	Apr. 1, 2020
Debt Instrument, Interest Rate, Stated Percentage	12.00%
Debt Instrument, Face Amount	$ 100,000
Convertible Notes Payable	0
Convertible Notes Payable12 Percent,100,000 [Member] | Non-Related Party [Member]
Convertible notes payable, current portion	0
Convertible notes payable, related parties, long term, net of current portion	100,000
Convertible Notes Payable12 Percent,100,000 [Member] | Related Party [Member]
Convertible notes payable, current portion	$ 0
Convertible Notes Payable, 12%, $4,570,000 [Member]
Maturity date	Apr. 1, 2020	Apr. 1, 2017
Debt Instrument, Interest Rate, Stated Percentage	12.00%	12.00%
Debt Instrument, Face Amount	$ 4,055,000	$ 4,055,000
Convertible Notes Payable	0	0
Convertible Notes Payable, 12%, $4,570,000 [Member] | Non-Related Party [Member]
Convertible notes payable, current portion	0	0
Convertible notes payable, related parties, long term, net of current portion	0	0
Convertible Notes Payable, 12%, $4,570,000 [Member] | Related Party [Member]
Convertible notes payable, current portion	$ 4,055,000	$ 4,055,000
Convertible Notes Payable, 12%, $215,000 [Member]
Maturity date		Apr. 1, 2018
Debt Instrument, Interest Rate, Stated Percentage		12.00%
Debt Instrument, Face Amount		$ 215,000
Convertible Notes Payable		0
Convertible Notes Payable, 12%, $215,000 [Member] | Non-Related Party [Member]
Convertible notes payable, current portion		0
Convertible notes payable, related parties, long term, net of current portion		215,000
Convertible Notes Payable, 12%, $215,000 [Member] | Related Party [Member]
Convertible notes payable, current portion		$ 0
Convertible Notes Payable, 12%, $100,000 issued 9/30/2009, Second Issuance [Member]
Maturity date	Apr. 1, 2018	Apr. 1, 2018
Debt Instrument, Interest Rate, Stated Percentage	12.00%	12.00%
Debt Instrument, Face Amount	$ 100,000	$ 100,000
Convertible Notes Payable	0	0
Convertible Notes Payable, 12%, $100,000 issued 9/30/2009, Second Issuance [Member] | Non-Related Party [Member]
Convertible notes payable, current portion	0	0
Convertible notes payable, related parties, long term, net of current portion	100,000	100,000
Convertible Notes Payable, 12%, $100,000 issued 9/30/2009, Second Issuance [Member] | Related Party [Member]
Convertible notes payable, current portion	$ 0	$ 0
Convertible Notes Payable, 12%, $25,000 [Member]
Maturity date		Apr. 1, 2018
Debt Instrument, Interest Rate, Stated Percentage		12.00%
Debt Instrument, Face Amount		$ 25,000
Convertible Notes Payable		0
Convertible Notes Payable, 12%, $25,000 [Member] | Non-Related Party [Member]
Convertible notes payable, current portion		0
Convertible notes payable, related parties, long term, net of current portion		0
Convertible Notes Payable, 12%, $25,000 [Member] | Related Party [Member]
Convertible notes payable, current portion		$ 25,000
Convertible Notes Payable 12% 1,300,000 [Member]
Maturity date	Apr. 1, 2020	Apr. 1, 2017
Debt Instrument, Interest Rate, Stated Percentage	12.00%	12.00%
Debt Instrument, Face Amount	$ 625,000	$ 625,000
Convertible Notes Payable	0	0
Convertible Notes Payable 12% 1,300,000 [Member] | Non-Related Party [Member]
Convertible notes payable, current portion	0	0
Convertible notes payable, related parties, long term, net of current portion	625,000	625,000
Convertible Notes Payable 12% 1,300,000 [Member] | Related Party [Member]
Convertible notes payable, current portion	$ 0	$ 0

Note 8 - Convertible Notes Pa55

Note 8 - Convertible Notes Payable - Convertible Debt Maturity Payments (Details) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Total	$ 0	$ 0
Convertible Debt [Member]
2,017	50,000
2,018	450,000
2,019	0
2,020	6,550,000
Total	$ 7,050,000

Note 9 - Fair Value Measureme56

Note 9 - Fair Value Measurement (Details Textual)	12 Months Ended
	Dec. 31, 2016
Minimum [Member]
Finite-Lived Intangible Asset, Useful Life	3 years
Maximum [Member]
Finite-Lived Intangible Asset, Useful Life	15 years

Note 9 - Fair Value Measureme57

Note 9 - Fair Value Measurement - Fair Value of Liabilities Measured on a Recurring Basis (Details) - USD ($)		Dec. 31, 2016	[2]	Dec. 31, 2015	[3]
Derivative Liability fair value	[1]	$ 6,325,092		$ 2,816,166
Fair Value, Inputs, Level 1 [Member]
Derivative Liability fair value	[1]	0		0
Fair Value, Inputs, Level 2 [Member]
Derivative Liability fair value	[1]	0		0
Fair Value, Inputs, Level 3 [Member]
Derivative Liability fair value	[1]	6,325,092		2,816,166
Conversion Feature Liability [Member]
Derivative Liability fair value	[1]	2,325,730		901,243
Conversion Feature Liability [Member] | Fair Value, Inputs, Level 1 [Member]
Derivative Liability fair value	[1]	0		0
Conversion Feature Liability [Member] | Fair Value, Inputs, Level 2 [Member]
Derivative Liability fair value	[1]	0		0
Conversion Feature Liability [Member] | Fair Value, Inputs, Level 3 [Member]
Derivative Liability fair value	[1]	2,325,730		901,243
Warrant Liability [Member]
Derivative Liability fair value	[1]	3,999,362		1,914,923
Warrant Liability [Member] | Fair Value, Inputs, Level 1 [Member]
Derivative Liability fair value	[1]	0		0
Warrant Liability [Member] | Fair Value, Inputs, Level 2 [Member]
Derivative Liability fair value	[1]	0		0
Warrant Liability [Member] | Fair Value, Inputs, Level 3 [Member]
Derivative Liability fair value	[1]	$ 3,999,362		$ 1,914,923
[1]	The fair value at the measurement date is equal to the carrying value on the balance sheet
[2]	The fair value of the derivative instruments was estimated using the Income Approach and the Black Scholes option pricing model with the following assumptions for the year ended December 31, 2016
[3]	The fair value of the derivative instruments was estimated using the Income Approach and the Black Scholes option pricing model with the following assumptions for the year ended December 31, 2015

Note 9 - Fair Value Measureme58

Note 9 - Fair Value Measurement - Fair Value Assumptions (Details)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Dividend yield	0.00%	0.00%
Minimum [Member]
Risk free interest rate	0.82%	0.48%
Expected volatility	117.30%	91.00%
Minimum [Member] | Conversion Feature Liability [Member]
Expected life (Year)	1 year 91 days	1 year 91 days
Minimum [Member] | Warrant Liability [Member]
Expected life (Year)	91 days	0 years
Maximum [Member]
Risk free interest rate	1.45%	1.20%
Expected volatility	143.80%	132.20%
Maximum [Member] | Conversion Feature Liability [Member]
Expected life (Year)	3 years 91 days	2 years 91 days
Maximum [Member] | Warrant Liability [Member]
Expected life (Year)	3 years 91 days	3 years 3 days

Note 9 - Fair Value Measureme59

Note 9 - Fair Value Measurement - Fair Value of Assets Acquired on Non-recurring Basis (Details) - USD ($)		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Promasys B.V. customer list	[1],[2]	$ 82,173	$ 92,444	$ 110,948
Promasys B.V. software code	[1],[2]	26,707	41,274	55,842
Promasys B.V. URLs/website	[1],[2]	0	15,159	37,131
Total	[2]	108,880	148,877	$ 203,921
Fair Value, Inputs, Level 1 [Member]
Promasys B.V. customer list	[1],[2]	0	0
Promasys B.V. software code	[1],[2]	0	0
Promasys B.V. URLs/website	[1],[2]	0	0
Total	[2]	0	0
Fair Value, Inputs, Level 2 [Member]
Promasys B.V. customer list	[1],[2]	0	0
Promasys B.V. software code	[1],[2]	0	0
Promasys B.V. URLs/website	[1],[2]	0	0
Total	[2]	0	0
Fair Value, Inputs, Level 3 [Member]
Promasys B.V. customer list	[1],[2]	136,253	136,253
Promasys B.V. software code	[1],[2]	72,943	72,943
Promasys B.V. URLs/website	[1],[2]	68,814	68,814
Total	[2]	$ 278,010	$ 278,010
[1]	The acquired Promasys B.V. software code, customer list and URLs/website are not measured on a recurring basis since their initial fair value has been deemed to have a finite life and is being amortized periodically. Instead the Company performs an impairment analysis on a quarterly basis in order to determine whether the carrying value of the assets reflects the fair value of the assets in a market based transaction.
[2]	The fair value of the acquired assets was estimated using the Income Approach with a discounted cash flow valuation methodology applied.

Note 9 - Fair Value Measureme60

Note 9 - Fair Value Measurement - Unrealized Gain or Loss Included in Earnings (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
The net amount of gains/(losses) for the period included in earnings attributable to the unrealized and realized gains/(losses) from changes in derivative liabilities at the reporting date	$ (2,657,910)	$ 4,525,798
Total unrealized and realized gains/(losses) included in earnings	$ (2,657,910)	$ 4,525,798

Note 9 - Fair Value Measureme61

Note 9 - Fair Value Measurement - Change in Level 3 Financial Liabilities Fair Value (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Balance beginning of year	$ (2,816,166)	$ (9,639,462)
Net realized gains/(losses)	29,108	29,875
Net unrealized gains/(losses) relating to instruments still held at the reporting date	(2,687,018)	4,495,923
Net purchases, issuances and settlements	(851,016)	(868,128)
Net transfers in and/or out of Level 3	0	3,165,626
Balance, end of period	(6,325,092)	(2,816,166)
Conversion Feature Liability [Member]
Balance beginning of year	(901,243)	(2,944,402)
Net realized gains/(losses)	29,108	29,875
Net unrealized gains/(losses) relating to instruments still held at the reporting date	(1,453,595)	2,013,284
Net purchases, issuances and settlements	0	0
Net transfers in and/or out of Level 3	0	0
Balance, end of period	(2,325,730)	(901,243)
Warrant Liability [Member]
Balance beginning of year	(1,914,923)	(6,695,060)
Net realized gains/(losses)	0	0
Net unrealized gains/(losses) relating to instruments still held at the reporting date	(1,233,423)	2,482,639
Net purchases, issuances and settlements	(851,016)	(868,128)
Net transfers in and/or out of Level 3	0	3,165,626
Balance, end of period	$ (3,999,362)	$ (1,914,923)

Note 10 - Commitments and Con62

Note 10 - Commitments and Contingencies (Details Textual)	1 Months Ended	12 Months Ended
	Jun. 30, 2009USD ($)	Dec. 31, 2016USD ($)$ / sharesshares	Dec. 31, 2015USD ($)$ / shares
Operating Leases, Rent Expense		$ 1,071,363	$ 972,862
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares
License Payments	$ 300,000
Other Expenses		$ 94,129	$ 244,747
Loss Contingency, Pending Claims, Number		0
Settlement and Licensing Agreement [Member]
Patent Royalty Percentage Obligation		2.00%
Anticipated Annual Royalty Payments		$ 450,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares		1,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 0.01
Loss Contingency, Estimate of Possible Loss		$ 300,000

Note 10 - Commitments and Con63

Note 10 - Commitments and Contingencies - Minimum Royalty Payments Per Year (Details)	Dec. 31, 2016USD ($)
2,017	$ 655,832
2,018	512,157
2,019	421,230
2,020	297,570
2,021	269,962
Thereafter	310,550
Total	$ 2,467,301

Note 10 - Commitments and Con64

Note 10 - Commitments and Contingencies - Future Minimum Lease Payments (Details)	Dec. 31, 2016USD ($)
2,017	$ 450,000
2,018	164,500
Total	$ 614,500

Note 11 - Related Party Trans65

Note 11 - Related Party Transactions (Details Textual)	Nov. 19, 2015USD ($)$ / sharesshares	May 01, 2015USD ($)	Jan. 31, 2015USD ($)$ / sharesshares	Jan. 01, 2014USD ($)$ / sharesshares	Mar. 18, 2013USD ($)	Dec. 31, 2009USD ($)shares	Dec. 16, 2008USD ($)$ / sharesshares	Sep. 30, 2009USD ($)$ / sharesshares	Aug. 29, 2008USD ($)$ / sharesshares	Dec. 31, 2016USD ($)$ / shares	Dec. 31, 2015USD ($)$ / sharesshares	Jun. 30, 2016USD ($)	Feb. 29, 2016USD ($)$ / sharesshares	Nov. 23, 2015USD ($)	Oct. 15, 2015USD ($)	Apr. 30, 2015USD ($)	Apr. 01, 2015USD ($)	Feb. 03, 2015USD ($)	Dec. 18, 2013USD ($)	Feb. 22, 2013USD ($)	Oct. 16, 2012USD ($)shares	Jun. 30, 2008USD ($)	Feb. 29, 2008USD ($)
Debt Instrument, Interest Rate, Stated Percentage					2.00%
Convertible Notes Payable										$ 0	$ 0
Debt Conversion, Converted Instrument, Amount										$ 0	$ 1,915,000
Class of Warrant or Right Cancelled During the Period | shares											29,363,517
Debt Instrument, Convertible, Number of Equity Instruments										15,490,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares
Line of Credit Facility, Maximum Borrowing Capacity					$ 2,000,000													$ 5,000,000	$ 4,000,000
Long-term Line of Credit										$ 2,700,000
Line of Credit Facility, Interest Rate at Period End										2.75%
Interest Expense, Related Party										$ 918,189	$ 2,434,101
The Northern Trust Company [Member]
Line of Credit Facility, Maximum Borrowing Capacity					$ 2,000,000													$ 5,000,000	$ 4,000,000
Line of Credit Facility, Interest Rate During Period					2.00%
Long-term Line of Credit										$ 2,700,000
Line of Credit Facility, Interest Rate at Period End										2.75%
Director Mr. Wit [Member]
Class of Warrant or Right Cancelled During the Period | shares	1,900,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares	$ 0.25
Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares | shares	37,023,517
Warrants Cancelled | shares	29,363,517
Interest Expense, Related Party Approximately Monthly Amount					$ 9,500
Chief Executive Officer [Member]
Notes Payable, Related Parties													$ 450,000
Debt Instrument, Interest Rate, Stated Percentage													12.00%
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares													1,800,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares													$ 0.25
Interest Payable													$ 450,000
12% Promissory Notes [Member] | Chairman and Chief Technology Officer [Member]
Debt Instrument, Interest Rate, Stated Percentage																	12.00%
Matures On April 1, 2017 [Member] | Director Mr. Wit [Member]
Class of Warrant or Right Cancelled During the Period | shares	11,440,000
12% Promissory Notes [Member] | Director Mr. Wit [Member]
Debt Instrument, Interest Rate, Stated Percentage	12.00%
Extinguishment of Debt, Amount	$ 6,919,000
12% Promissory Notes [Member] | Chairman and Chief Technology Officer [Member]
Notes Payable, Related Parties																	$ 20,000
Convertible Debentures [Member] | Chief Operating Officer [Member]
Debt Instrument, Interest Rate, Stated Percentage																12.00%
Convertible Notes Payable																$ 25,000
Convertible Debentures [Member] | Director Mr. Wit [Member]
Convertible Notes Payable																						$ 510,000
Due to Related Parties										$ 5,825,000
Debt Conversion, Converted Instrument, Amount									$ 510,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares	5,760,000
Convertible Debentures [Member] | Chairman and Chief Technology Officer [Member]
Debt Instrument, Interest Rate, Stated Percentage		12.00%
Related Party Transaction, Amounts of Transaction		$ 5,000
Promissory Notes [Member] | CEO And Director [Member]
Notes Payable, Related Parties										$ 450,000
Convertible Debenture Initiated In June 2008 [Member] | Director Mr. Wit [Member]
Debt Instrument, Interest Rate, Stated Percentage									10.00%
Convertible Notes Payable			$ 1,770,000					$ 1,770,000	$ 1,260,000			$ 1,770,000								$ 1,770,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares									3,540,000
Debt Instrument, Convertible, Conversion Price | $ / shares									$ 0.50
Convertible Debenture Initiated In February 2008 [Member] | Director Mr. Wit [Member]
Notes Payable, Related Parties																							$ 150,000
Convertible Notes Payable			4,475,000					$ 4,350,000												$ 4,475,000	$ 125,000		$ 4,200,000
Debt Conversion, Converted Instrument, Amount							$ 4,350,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares	1,680,000						8,700,000														250,000
Debt Instrument, Convertible, Conversion Price | $ / shares							$ 0.50
Debt Conversion, Converted Instrument, Rate							12.00%
Extinguishment of Debt, Amount	$ 420,000
Class of Warrant or Right Cancelled During the Period | shares	1,680,000
Convertible Debenture Initiated In February 2008 [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures [Member]
Convertible Notes Payable												$ 4,055,000
Aggregated Convertible Debt July - September 30, 2009 [Member]
Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares | shares	1,900,000
Aggregated Convertible Debt July - September 30, 2009 [Member] | Director Mr. Wit [Member]
Debt Instrument, Interest Rate, Stated Percentage								12.00%
Convertible Notes Payable			1,100,000					$ 1,100,000
Debt Conversion, Converted Instrument, Amount	$ 475,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares	1,900,000							4,400,000
Extinguishment of Debt, Amount	$ 475,000
Class of Warrant or Right Cancelled During the Period | shares	1,900,000
Debt Instrument, Convertible, Number of Equity Instruments								4,400,000
Warrants and Rights Outstanding								$ 4,400,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares								$ 0.25
Warrants Extension of Maturity								2 years
Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares | shares	5,760,000
Notes Payable Related Parties Amount Transfered														$ 625,000
Aggregated Convertible Debt October - December 31, 2009 [Member] | Director Mr. Wit [Member]
Debt Instrument, Interest Rate, Stated Percentage						12.00%
Convertible Notes Payable			1,440,000			$ 1,440,000
Debt Conversion, Converted Instrument, Amount	$ 1,440,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares						5,760,000
Extinguishment of Debt, Amount	$ 1,440,000
Class of Warrant or Right Cancelled During the Period | shares	5,760,000
Warrants Extension of Maturity						2 years
Matures On April 1, 2017 [Member] | Accrued Interest [Member]
Extinguishment of Debt, Amount				$ 980,000
Matures On April 1, 2017 [Member] | Director Mr. Wit [Member]
Notes Payable, Related Parties			2,860,000	$ 980,000											$ 980,000
Debt Instrument, Interest Rate, Stated Percentage				12.00%											12.00%
Related Party Transaction, Amounts of Transaction			6,879
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares				3,920,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares				$ 0.25
Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares | shares	11,440,000
Matures on January 1, 2019 [Member] | Director Mr. Wit [Member]
Debt Instrument, Interest Rate, Stated Percentage															12.00%
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares	3,920,000
Matures on April 1, 2019 [Member] | Director Mr. Wit [Member]
Notes Payable, Related Parties															$ 2,860,000
Matures On April 1, 2017 II [Member] | Director Mr. Wit [Member]
Notes Payable, Related Parties			$ 529,000
Matures On April 1, 2017 II [Member] | Director Mr. Wit [Member] | Notes Payable, Other Payables [Member]
Debt Instrument, Interest Rate, Stated Percentage			12.00%
Matures On January 1, 2019 II [Member] | Director Mr. Wit [Member]
Notes Payable, Related Parties															$ 529,000
Debt Instrument, Interest Rate, Stated Percentage															12.00%
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares	2,116,000
Matures On April 1, 2017 III [Member] | Director Mr. Wit [Member]
Notes Payable, Related Parties			$ 950,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares			3,800,000
Extinguishment of Debt, Amount			$ 280,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares			$ 0.25
Matures On April 1, 2017 III [Member] | Director Mr. Wit [Member] | Accrued Interest [Member]
Extinguishment of Debt, Amount			$ 670,000
Matures On January 1, 2019 IV [Member] | Director Mr. Wit [Member]
Notes Payable, Related Parties															$ 950,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares	3,800,000
Matures On January 1, 2019 III [Member] | Director Mr. Wit [Member]
Debt Instrument, Interest Rate, Stated Percentage															12.00%
12% Percent Convertible Notes Payable [Member] | Director Mr. Wit [Member]
Debt Instrument, Interest Rate, Stated Percentage	12.00%
Debt Conversion, Converted Instrument, Amount	$ 1,915,000
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 0.25
Extinguishment of Debt, Amount	$ 420,000

Note 12 - Stockholders' (Defi66

Note 12 - Stockholders' (Deficit) (Details Textual)	Dec. 30, 2016shares	Jul. 20, 2016shares	Jun. 16, 2016shares	Apr. 26, 2016shares	Apr. 25, 2016shares	Apr. 13, 2016shares	Dec. 31, 2015$ / sharesshares	Nov. 19, 2015USD ($)$ / sharesshares	Oct. 16, 2015shares	Aug. 21, 2015shares	Jul. 17, 2015shares	Jun. 30, 2015shares	Jun. 15, 2015shares	Jun. 11, 2015shares	Apr. 29, 2015shares	Mar. 23, 2015shares	Mar. 20, 2015shares	Dec. 31, 2015$ / sharesshares	Apr. 30, 2016shares	Dec. 31, 2016USD ($)$ / sharesshares	Dec. 31, 2015USD ($)$ / sharesshares	Dec. 31, 1999shares	Dec. 31, 2014shares	Dec. 31, 2016USD ($)$ / sharesshares	Dec. 31, 2016USD ($)$ / sharesshares	Mar. 18, 2013	Nov. 30, 2010shares	Mar. 31, 2002shares	Feb. 07, 2002shares	Aug. 31, 2001shares
Common Stock, Shares Authorized							500,000,000											500,000,000		500,000,000	500,000,000			500,000,000	500,000,000
Preferred Stock, Shares Authorized							10,000,000											10,000,000		10,000,000	10,000,000			10,000,000	10,000,000
Common Stock, Shares, Issued							131,703,577											131,703,577		147,786,917	131,703,577			147,786,917	147,786,917
Class of Warrant or Right, Issued																				27,860,000				27,860,000	27,860,000
Convertible Debt | $																				$ 7,050,000				$ 7,050,000	$ 7,050,000
Debt Instrument, Convertible, Number of Equity Instruments																				15,490,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period																				1,120,000	292,500
Debt Instrument, Interest Rate, Stated Percentage																										2.00%
Preferred Stock, Amount of Preferred Dividends in Arrears | $																				$ 2,081,980	$ 4,547,810
Preferred Stock, Par or Stated Value Per Share | $ / shares							$ 0.001											$ 0.001		$ 0.001	$ 0.001			$ 0.001	$ 0.001
Common Stock, Shares, Outstanding							131,703,577											131,703,577		147,786,917	131,703,577			147,786,917	147,786,917
Class of Warrant or Right, Outstanding							22,900,000											22,900,000		27,860,000	22,900,000		48,463,517	27,860,000	27,860,000
Conversion of Series A Preferred Stock into Common Shares [Member]
Conversion of Stock, Shares Converted							487,500												3,637,724
Stock Issued During Period, Shares, Conversion of Convertible Securities							1,950,000												14,615,696
Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period																				1,100,000	252,500
Stock Issued During Period, Shares, Conversion of Convertible Securities																				14,615,696	1,950,000
Employee [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period		3,038		1,594	1,000,000	3,012
Chief Executive Officer [Member]
Debt Conversion, Original Debt, Amount | $								$ 1,915,000
Debt Instrument, Convertible, Conversion Price | $ / shares								$ 0.25
Chief Executive Officer [Member] | 12% Promissory Notes [Member]
Extinguishment of Debt, Amount | $								$ 6,919,000
Debt Instrument, Interest Rate, Stated Percentage								12.00%
Chief Executive Officer [Member] | 12% Percent Convertible Notes Payable [Member]
Extinguishment of Debt, Amount | $								$ 420,000
Debt Instrument, Interest Rate, Stated Percentage								12.00%
Chief Executive Officer [Member] | Common Stock [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross								37,023,517
Warrants Cancelled								29,363,517
Warrants Cancelled, Price Per Share of Common Stock | $ / shares								$ 0.25
Chief Financial Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	100,000
Restricted Stock [Member] | Former Employee [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period									50,002		66,668
Employee Stock Option [Member] | Former Employee [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period																7,500
Employee Stock Option [Member] | Employee [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period										1,628		20,000	225,000		5,800
Equity Incentive Plan 2009 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period																				5 years
Equity Incentive Plan 2009 [Member] | Director [Member] | Common Stock [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross			360,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period			3 years
Equity Incentive Plan 2009 [Member] | Restricted Stock [Member] | Senior Management Team [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross																	665,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period																	3 years
Equity Incentive Plan 2009 [Member] | Restricted Stock [Member] | Board of Directors Chairman [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross														360,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period														3 years
Series A Preferred Stock [Member]
Preferred Stock, Shares Authorized							5,000,000											5,000,000		5,000,000	5,000,000	5,000,000		5,000,000	5,000,000
Preferred Stock, Dividend Rate, Percentage							5.00%													5.00%		5.00%	5.00%
Preferred Stock, Shares Outstanding							3,637,724											3,637,724		0	3,637,724			0	0
Conversion of Stock, Shares Converted																							235,000
Stock Issued During Period, Shares, Conversion of Convertible Securities																				(3,637,724)	(487,500)
Convertible Preferred Stock, Conversion Price | $ / shares																				$ 1.11
Convertible Preferred Stock, Conversion Term																				1 year
Convertible Preferred Stock, Stock Price Trigger | $ / shares																				$ 3
Convertible Preferred Stock, Threshold Consecutive Trading Days																				20 days
Preferred Stock, Redemption Price Per Share | $ / shares																				$ 1				$ 1	$ 1
Preferred Stock, Liquidation Preference Per Share | $ / shares																				$ 1				1	1
Voting Rights, Number of Votes																				1
Preferred Stock, Amount of Preferred Dividends in Arrears | $																				$ 0	$ 2,465,830
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears | $ / shares																				$ 0	$ 0.68
Number of Shareholders, Exchange Offer Initiated																		34
Convertible Preferred Stock, Shares Issued upon Conversion							4											4			4
Number of Shareholders, Exchange Offer Accepted							4
Preferred Stock, Par or Stated Value Per Share | $ / shares							$ 0.001											$ 0.001		$ 0.001	$ 0.001			$ 0.001	$ 0.001
Preferred Stock, Shares Issued							3,637,724											3,637,724		0	3,637,724			0	0
Series B Preferred Stock [Member]
Preferred Stock, Shares Authorized							230,000											230,000		230,000	230,000			230,000	230,000				230,000	200,000
Preferred Stock, Dividend Rate, Percentage																				8.00%
Preferred Stock, Shares Outstanding							0											0		0	0			0	0
Conversion of Stock, Shares Converted																									200,000
Convertible Preferred Stock, Stock Price Trigger | $ / shares																				$ 0.50
Convertible Preferred Stock, Threshold Consecutive Trading Days																				20 years
Preferred Stock, Redemption Price Per Share | $ / shares																				$ 10				$ 10	$ 10
Preferred Stock, Liquidation Preference Per Share | $ / shares																				$ 10				10	10
Voting Rights, Number of Votes																				1
Preferred Stock, Amount of Preferred Dividends in Arrears | $																				$ 609,887	$ 609,887
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears | $ / shares																				$ 3.05	$ 3.05
Share Price | $ / shares																				$ 0.25				0.25	0.25
Convertible Preferred Stock, Public Offering Proceeds Threshold | $																				$ 25,000,000
Voting Rights, Number of Members of Board of Congress																				1
Preferred Stock, Par or Stated Value Per Share | $ / shares							$ 0.001											$ 0.001		$ 0.001	$ 0.001			$ 0.001	$ 0.001
Preferred Stock, Shares Issued							0											0		0	0			0	0
Series C Preferred Stock [Member]
Preferred Stock, Shares Authorized							747,500											747,500		747,500	747,500			747,500	747,500			747,500
Preferred Stock, Dividend Rate, Percentage																				8.00%
Preferred Stock, Shares Outstanding							0											0		0	0			0	0
Conversion of Stock, Shares Converted																								337,150
Convertible Preferred Stock, Threshold Consecutive Trading Days																				20 days
Preferred Stock, Liquidation Preference Per Share | $ / shares																				$ 10				$ 10	$ 10
Voting Rights, Number of Votes																				1
Preferred Stock, Amount of Preferred Dividends in Arrears | $																				$ 1,472,093	$ 1,472,093
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears | $ / shares																				$ 4.37	$ 4.37
Share Price | $ / shares																				$ 0.25				0.25	0.25
Convertible Preferred Stock, Public Offering Proceeds Threshold | $																				$ 25,000,000
Voting Rights, Number of Members of Board of Congress																				2
Convertible Preferred Stock, Offering Price Threshold Ratio																				2.5
Preferred Stock, Par or Stated Value Per Share | $ / shares							$ 0.001											$ 0.001		$ 0.001	$ 0.001			$ 0.001	$ 0.001
Preferred Stock, Shares Issued							0											0		0	0			0	0
Series D Preferred Stock [Member]
Preferred Stock, Shares Authorized							250,000											250,000		250,000	250,000			250,000	250,000		250,000
Preferred Stock, Shares Outstanding							250,000											250,000		250,000	250,000			250,000	250,000
Preferred Stock, Liquidation Preference Per Share | $ / shares																				$ 0.001				$ 0.001	$ 0.001
Voting Rights, Number of Votes																				400
Preferred Stock, Par or Stated Value Per Share | $ / shares							$ 0.001											$ 0.001		$ 0.001	$ 0.001			$ 0.001	$ 0.001
Preferred Stock, Right of First Refusal																				30 days
Preferred Stock, Shares Issued							250,000											250,000		250,000	250,000			250,000	250,000
Convertible Series B Preferred Stock [Member]
Share Price | $ / shares																				$ 0.75				$ 0.75	$ 0.75

Note 12 - Stockholders' (Defi67

Note 12 - Stockholders' (Deficit) - Cumulative Arrearage of Undeclared Dividends (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Preferred Stock, Amount of Preferred Dividends in Arrears	$ 2,081,980	$ 4,547,810
Series A Preferred Stock [Member]
Preferred Stock, Amount of Preferred Dividends in Arrears	$ 0	$ 2,465,830
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears	$ 0	$ 0.68
Series B Preferred Stock [Member]
Preferred Stock, Amount of Preferred Dividends in Arrears	$ 609,887	$ 609,887
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears	$ 3.05	$ 3.05
Series C Preferred Stock [Member]
Preferred Stock, Amount of Preferred Dividends in Arrears	$ 1,472,093	$ 1,472,093
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears	$ 4.37	$ 4.37

Note 12 - Stockholders' (Defi68

Note 12 - Stockholders' (Deficit) - Dividends Payable (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Series A Preferred Stock [Member]
Dividends accreted	$ 0	$ 181,886
Divideds accreted per share (in dollars per share)	$ 0	$ 0.05
Series B Preferred Stock [Member]
Dividends accreted	$ 0	$ 0
Divideds accreted per share (in dollars per share)	$ 0	$ 0
Series C Preferred Stock [Member]
Dividends accreted	$ 0	$ 0
Divideds accreted per share (in dollars per share)	$ 0	$ 0

Note 12 - Stockholders' (Defi69

Note 12 - Stockholders' (Deficit) - Warrants (Details) - $ / shares	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Class of Warrant or Right, Exercise Price of Warrants or Rights
Class of Warrant or Right, Outstanding	27,860,000	22,900,000	48,463,517
Weighted average remaining contractual life (Year)	2 years 259 days	1 year 277 days
Weighted average exercise price (in dollars per share)	$ 0.42	$ 0.46
Warrants exercisable at December 31, 2016 (in shares)	27,860,000	22,900,000
Warrants exercisable Weighted average exercise price (in dollars per share)	$ 0.42	$ 0.46
Minimum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights	0.25	0.25
Maximum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.60	$ 0.60

Note 12 - Stockholders' (Defi70

Note 12 - Stockholders' (Deficit) - Warrants Activity (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Balance (in shares)	22,900,000	48,463,517
Issued (in shares)	4,970,000	3,800,000
Exercised (in shares)	0	0
Cancelled (in shares)		(29,363,517)
Expired/forfeited (in shares)	(10,000)	0
Balance (in shares)	27,860,000	22,900,000
Warrants exercisable at December 31, 2016 (in shares)	27,860,000	22,900,000
Weighted average fair value of warrants granted during 2016	$ 0.16

Note 12 - Stockholders' (Defi71

Note 12 - Stockholders' (Deficit) - Accumulated Other Comprehensive Gain (Loss) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Balance	$ (21,418,474)	$ (35,774,832)
Balance	(21,127,798)	(21,418,474)
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Balance	(366,355)	(243,827)
Activity	(44,150)	(122,528)
Balance	(410,505)	(366,355)
AOCI Attributable to Parent [Member]
Balance	(366,355)	(243,827)
Activity	(44,150)	(122,528)
Balance	$ (410,505)	$ (366,355)

Note 13 - Employee Equity Inc72

Note 13 - Employee Equity Incentive Plans (Details Textual) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number		1,225,000	2,002,500	3,130,000
Proceeds from Stock Options Exercised		$ 129,500	$ 27,250
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value		$ 0.19	$ 0.24
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options		$ 76,846
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition		2 years 138 days
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense		$ 0	$ 0
The 2016 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized		10,000,000
Common Stock Available for Issuance Increasing Period		9 years
Common Stock Available for Issuance, Annual Increase Percent		5.00%
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period		5 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number		450,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant		9,550,000
The 2016 Plan [Member] | Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	50.00%
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period		1 year
The 2016 Plan [Member] | Share-based Compensation Award, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period		2 years
The 2016 Plan [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement, Installments for Vesting		2
The 2016 Plan [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number		0
The 2016 Plan [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period		10 years
Equity Incentive Plan 2009 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized		7,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period		5 years
Share-based Compensation Arrangement, Installments for Vesting		2
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number		775,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant		0
Equity Incentive Plan 2009 [Member] | Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage		50.00%
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period		1 year
Equity Incentive Plan 2009 [Member] | Share-based Compensation Award, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period		2 years
Equity Incentive Plan 2009 [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number		3,893,330
Equity Incentive Plan 2009 [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period		10 years

Note 13 - Employee Equity Inc73

Note 13 - Employee Equity Incentive Plans - Stock Option Activity (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Number of shares (in shares)	2,002,500	3,130,000
Weighted average exercise price (per share) (in dollars per share)	$ 0.14	$ 0.20
Weighted average remaining contractual term (in years) (Year)	2 years 226 days	1 year 146 days	1 year 215 days
Aggregate intrinsic value	$ 83,425	$ 198,990	$ 364,900
Number of shares, granted (in shares)	450,000	225,000
Weighted average exercise price (per share), granted (in dollars per share)	$ 0.20	$ 0.25
Number of shares, exercised (in shares)	(1,120,000)	(292,500)
Weighted average exercise price (per share), exercised (in dollars per share)	$ 0.12	$ 0.12
Number of shares, forfeited/cancelled/expired (in shares)	(107,500)	(1,060,000)
Weighted average exercise price (per share), forfeited/cancelled/expired (in dollars per share)	$ 0.29	$ 0.35
Number of shares (in shares)	1,225,000	2,002,500	3,130,000
Weighted average exercise price (per share) (in dollars per share)	$ 0.17	$ 0.14	$ 0.20
Vested and exercisable at December 31, 2016 (in shares)	737,500
Vested and exercisable at December 31, 2016 (in dollars per share)	$ 0.15
Vested and exercisable at December 31, 2016 (Year)	1 year 138 days
Vested and exercisable at December 31, 2016	$ 64,550

Note 13 - Employee Equity Inc74

Note 13 - Employee Equity Incentive Plans - Vested Shares (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Number of options vested (in shares)	162,500	200,000
Fair value of options vested	$ 33,622	$ 34,665

Note 13 - Employee Equity Inc75

Note 13 - Employee Equity Incentive Plans - Stock Options Outstanding (Details) - $ / shares	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Low Price range (in dollars per share)	$ 0	$ 0
High Price range (in dollars per share)	$ 0.70	$ 0.70
Outstanding stock options (in shares)	1,225,000	2,002,500
Weighted average remaining contractual life - outstanding (Year)	2 years 226 days	1 year 146 days
Weighted average outstanding strike price - outstanding (in dollars per share)	$ 0.17	$ 0.14
Vested stock options (in shares)	737,500	1,752,500
Weighted average remaining contractual life - vested (Year)	1 year 138 days	1 year 7 days
Weighted average outstanding strike price - vested (in dollars per share)	$ 0.15	$ 0.13
Range One [Member]
Low Price range (in dollars per share)	0	0
High Price range (in dollars per share)	$ 0.20	$ 0.20
Outstanding stock options (in shares)	850,000	1,777,500
Weighted average remaining contractual life - outstanding (Year)	2 years 54 days	1 year 51 days
Weighted average outstanding strike price - outstanding (in dollars per share)	$ 0.15	$ 0.13
Vested stock options (in shares)	625,000	1,652,500
Weighted average remaining contractual life - vested (Year)	1 year 116 days	339 days
Weighted average outstanding strike price - vested (in dollars per share)	$ 0.14	$ 0.13
Range Two [Member]
Low Price range (in dollars per share)	0.21	0.21
High Price range (in dollars per share)	$ 0.29	$ 0.29
Outstanding stock options (in shares)	375,000	125,000
Weighted average remaining contractual life - outstanding (Year)	3 years 255 days	2 years 302 days
Weighted average outstanding strike price - outstanding (in dollars per share)	$ 0.23	$ 0.22
Vested stock options (in shares)	112,500	100,000
Weighted average remaining contractual life - vested (Year)	1 year 244 days	2 years 167 days
Weighted average outstanding strike price - vested (in dollars per share)	$ 0.21	$ 0.21
Range Three [Member]
Low Price range (in dollars per share)	0.30	0.30
High Price range (in dollars per share)	$ 0.49	$ 0.49
Outstanding stock options (in shares)	0	100,000
Weighted average remaining contractual life - outstanding (Year)	0 years	4 years 62 days
Weighted average outstanding strike price - outstanding (in dollars per share)	$ 0	$ 0.30
Vested stock options (in shares)	0	0
Weighted average remaining contractual life - vested (Year)	0 years	0 years
Weighted average outstanding strike price - vested (in dollars per share)	$ 0	$ 0
Range Four [Member]
Low Price range (in dollars per share)	0.50	0.50
High Price range (in dollars per share)	$ 0.70	$ 0.70
Outstanding stock options (in shares)	0	0
Weighted average remaining contractual life - outstanding (Year)	0 years	0 years
Weighted average outstanding strike price - outstanding (in dollars per share)	$ 0	$ 0
Vested stock options (in shares)	0	0
Weighted average remaining contractual life - vested (Year)	0 years	0 years
Weighted average outstanding strike price - vested (in dollars per share)	$ 0	$ 0

Note 13 - Employee Equity Inc76

Note 13 - Employee Equity Incentive Plans - Fair Value Assumptions of Share-based Payments (Details)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Risk-free interest rate	1.45%	1.20%
Expected dividend yield	0.00%	0.00%
Expected volatility	155.50%	183.80%
Expected life of options (in years) (Year)	5 years	5 years

Note 13 - Employee Equity Inc77

Note 13 - Employee Equity Incentive Plans - Weighted Average Grant Date Fair Value Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Stock options granted during the period (in dollars per share)	$ 0.19	$ 0.24
Stock options vested during the period (in dollars per share)	0.21	0.17
Stock options forfeited during the period (in dollars per share)	$ 0.28	$ 0.26

Note 13 - Employee Equity Inc78

Note 13 - Employee Equity Incentive Plans - Status of Non-vested Shares (Details) - $ / shares	Dec. 31, 2016	Dec. 31, 2015
Shares underlying stock options (in shares)	487,500	250,000
Weighted average grant date fair value (in dollars per share)	$ 0.20	$ 0.23

Note 14 - Income Taxes (Details

Note 14 - Income Taxes (Details Textual)	12 Months Ended
	Dec. 31, 2016USD ($)
Operating Loss Carryforwards	$ 35,363,091
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ (1,158,278)

Note 14 - Income Taxes - Reconc

Note 14 - Income Taxes - Reconciliation of Income Tax Expense (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Federal statutory rate applied to income/(loss) before income taxes	$ 38,740	$ 963,947
Increase/(decrease) in income taxes results from:
Current tax expense/(benefit)	1,069	(24,739)
Nondeductible expenses	1,078,519	(1,451,221)
Change in deferred assets	41,019	97,580
Change in valuation allowance	(1,158,278)	389,694
Income tax expense/(benefit)	$ 1,069	$ (24,739)

Note 14 - Income Taxes - Compon

Note 14 - Income Taxes - Components of Income Tax Expense (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Current tax expense/(benefit)	$ 1,069	$ (24,739)
Deferred tax expense/(benefit)	1,159,347	(414,433)
Change in valuation allowance	(1,158,278)	389,694
Total tax expense/(benefit)	1,069	(24,739)
Bad Debt Allowance [Member]
Deferred tax expense/(benefit)	(23,699)	26,059
Operating Loss Carryforward [Member]
Deferred tax expense/(benefit)	1,140,957	(513,333)
Amortization of Intangibles [Member]
Deferred tax expense/(benefit)	5,482	5,482
Patent Litigation Settlement [Member]
Deferred tax expense/(benefit)	$ 35,538	$ 92,098

Note 14 - Income Taxes - Deferr

Note 14 - Income Taxes - Deferred Income Taxes (Details) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Amortization of intangibles	$ 267,253	$ 272,734
Bad debt allowance	66,662	42,963
Patent litigation liability accrual	128,804	164,342
Operating loss carryforwards	19,034,573	20,175,531
Gross deferred tax assets	19,497,292	20,655,570
Valuation allowance	(19,497,292)	(20,655,570)
Net deferred tax liability/(asset)	$ 0	$ 0

Note 15 - Subsequent Events (De

Note 15 - Subsequent Events (Details Textual) - USD ($)	Mar. 24, 2017	Mar. 27, 2017	Dec. 31, 2016	Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			450,000	225,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price			$ 0.20	$ 0.25
Subsequent Event [Member]
Repayments of Lines of Credit		$ 400,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	500,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price	$ 0.25
Subsequent Event [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	16,668